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Summary
The cell is the building block of life. Understanding how cells work is a major
challenge. Cellular processes are governed and coordinated by a multitude of biological
pathways, each of which can be viewed as a complex network of biochemical reactions
involving biomolecules (proteins, metabolite, RNAs). Thus it is necessary to have a
system-level understating of cellular functions and behavior and to so, one must develop
quantitative models.
Currently, a widely used means of modeling biological pathways is a system of
ordinary differential equations (ODEs). Since biological pathways are often complex
and involve a large number of reactions, the corresponding ODE systems will not admit
closed form solutions. Hence to analyze the pathway dynamics one will have to use
numerical simulations. However, the number of simulations required to carry out model
calibration and analysis tasks can become very large due to the following facts: Models
often contain many unknown parameters (rate constants in the differential equations
and initial concentration levels). Estimating their values will require a large number of
simulations. This also happens when performing tasks such as global sensitivity analysis
that involve sampling the high-dimensional value space induced by model parameters.
Further, the experimental data used for training and testing the model are often cell
population-based and have limited precision. Consequently, to simulate the model
and compare with such data, one must resort to Monte Carlo methods to ensure that
sufficiently many values from the distribution of model parameters are being sampled.
A major contribution of this thesis is to develop a computational approach by
which one can approximate the pathway dynamics defined by a system of ODEs as a
dynamic Bayesian network. Using this approximation, one can then efficiently carry
out model calibration and analysis tasks. Broadly speaking, our approach consists of
the following steps: (i) discretize the value space and the time domain; (ii) sample the
initial states of the system according to an assumed prior distribution; (iii) generate a
trajectory for each sampled initial state and view the resulting set of trajectories as an
approximation of the dynamics defined by the ODEs system; (iv) store the generated set
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of trajectories compactly as a dynamic Bayesian network and use Bayesian inference
techniques to perform analysis. This method has several advantages. Firstly, the
discretized nature of the approximation helps to bridge the gap between the accuracy of
the results obtained by ODE simulation and the limited precision of experimental data
used for calibration and validation. Secondly and more importantly, after investing in
this one-time construction cost, many interesting pathway properties can be analyzed
efficiently through standard Bayesian inference techniques instead of resorting to a
large number of ODE simulations.
We have demonstrated the applicability of our technique with the help of three
case studies. First, we tested our method on an EGF-NGF signaling pathway model
(Brown et al., 2004). We constructed the DBN approximation and used synthetic
data to perform parameter estimation and global sensitivity analysis. The results show
improved performance easily amortizing the cost of constructing the approximation. It
also is sufficiently accurate given the lack of precision and noise in the experimental
data. We further demonstrated this in the second case study using a segmentation
clock pathway model taken from Goldbeter and Pourquie (2008).
In the third case study, we built and analyzed a pathway model of the complement
system consisting of the lectin and classical pathways in collaboration with biologists
and clinicians (Liu et al., 2011). Using our approximation technique, we efficiently
trained the DBN model on in vivo experimental data and explored the key network
features. Our combined computational and experimental study showed that the antimi-
crobial response is sensitive to changes in pH and calcium levels, which determines the
strength of the crosstalk between two receptors called CRP and L-ficolin. Our study
also revealed differential regulatory effects of the inhibitor C4BP. While C4BP delays
but does not attenuate the classical pathway, it attenuates but does not delay the lectin
pathway. Further, we found that the major inhibitory role of C4BP is to facilitate the
decay of C3 convertase. These results elucidate the regulatory mechanisms of the com-
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Cells are the basic units of life. Understanding how cells function is one of the great-
est challenges facing science. The rewards of success will range from better medical
therapies to new generation of biofuels. Over the past decades, numerous experimental
techniques, such as microscopy, polymerase chain reaction (PCR), western blot, flow
cytometry, and fluorescence resonance energy transfer (FRET), have been developed to
help biologists to investigate how cells work. Consequently, biology has made amazing
advances on characterizing components inside the cell as well as identifying their inter-
actions. These components are often referred as biomolecules, including large molecules
such as proteins, DNA, RNA, and polysaccharides, as well as small molecules such as
metabolites, sugars, lipids, vitamins, and hormones. The cell is like a hugely complex
machine consisting of millions of such basic parts, which are interacting with each other
and carrying out diverse cellular functions.
Conventional biology research, which focuses on identifying components and inter-
actions inside the cell, culminates in the emerging of a variety of fields of studies with
the suffix -omics, such as genomics, proteomics, metabolomics, lipidomics, and inter-
actomics. These fields aim to describe and integrate complete sets of knowledge about
biomolecules, resulting in a range of biological databases including gene databases
1
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such as Entrez1 and GeneCards2, protein databases such as UniProt3 and PDB4, as
well as the protein-protein interaction databases such as BioGRID5 and BIND6. Hence,
roughly speaking, we already have a general picture of the basic constituents of the cell.
However, it is still far from an in-depth understanding of cellular processes, because
biomolecules do not function alone but exist in highly regulated complex assemblies
and networks. The next step in this line of research is to develop a systematic view
of how cells work, how cellular processes are regulated, and how cells response to their
changing internal and external environments.
This has motivated the emerging domain of systems biology that seeks to understand
how the individual biomolecules interact and evolve in time and space to realize the
various cellular functions. Systems biology integrates many different disciplines such as
biology, mathematics, physics, chemistry, computer science, and engineering. A long-
term vision of this field is to put all the relevant biological processes together and build
a model that can simulate the whole cell or even an entire organism. Such models
will have a substantial impact on our health care, food supplies and many other issues
that are essential to our survival. It will not only lead to a better understanding of
physiological mechanisms and human diseases, but also bring about more efficient drug
development and validation processes. Furthermore, with the help of models, we may
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1.1 Context and Motivation
To achieve the long-term vision of systems biology, one must describe fundamental
intra- and intercellular processes. The cellular processes are driven by networks of
biochemical reactions, which have been termed biological pathways. This thesis focuses
on modeling and analyzing the dynamics of biological pathways. Among the current
modeling formalisms, a system of ordinary differential equations (ODEs) is the most
widely used one to model pathway dynamics (Aldridge et al., 2006; Materi and Wishart,
2007). In the past few decades, many ODE models have been developed to study
pathways governing various cellular functions ranging from cell cycle to cell death
(Marlovits et al., 1998; Legewie et al., 2006). Due to the popularity of ODE-based
modeling, standard markup languages such as SBML (Hucka et al., 2003) have been
proposed for efficient model exchange and reuse. Hundreds of software systems were
developed for editing, simulating and storing models. For instance, the BioModels
database (Le Novere et al., 2006; Li et al., 2010) archives more than 200 published
ODE models covering many of the known biological pathways.
ODE models enable many kinds of model analysis, such as sensitivity, perturbation,
and population-based analysis that can be performed by solving the ODEs with dif-
ferent initial conditions and parameters. For instance, Spencer et al. (2009) discovered
that the difference in initial concentrations of proteins regulating apoptosis signaling
pathways is the primary cause of the cell-to-cell variability in the timing and probabil-
ity of cell death, which may explain why only a fraction of tumor cells will be killed
after exposure to chemotherapy. Another striking example is by Lee et al. (2007), who
used ODE models to significantly increase the productivity of L-threonine, an amino
acid that has been widely used in industries of cosmetics and pharmacy.
The ODE-based modeling has become a major approach in systems biology. How-
ever, to gain success in practical applications, there are several challenges to be ad-
dressed.
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• Large-scale pathways. Biological pathways are often complex and involve a
large number of biochemical reactions (Weng et al., 1999; Lauffenburger, 2000).
For example, the ErbB signaling pathway model built by Chen et al. (2009)
consisting of 828 reactions among 499 species. Hence the corresponding systems of
ODEs will not admit closed form solutions. Instead, one will have to use numerical
integration methods such as Runge-Kutta to perform model simulations as well
as analysis. The challenge here is that numerically simulating high dimensional
ODE systems will be computational intensive.
• Experimental data. Experimental data will be needed for the model develop-
ment. Assuming parameter values are known, analysis will consist of comparing
simulated behavior with experimental data. However, the data generated will
only have very limited precision. Specifically, the initial concentration levels of
the various proteins and rate constants will often be available only as intervals
of values. Further, experimental data in terms of the concentration levels of a
few proteins at a small number of time points will also be available only in terms
of intervals of values. In addition, the data will often be gathered using a popu-
lation of cells. Hence the data will represent the average concentration levels of
proteins in many different cells. Consequently, when numerically simulating the
ODE model, one must resort to Monte Carlo methods to ensure that sufficiently
many values from the relevant intervals are being sampled. As a result, generat-
ing a single prediction to compare with the experimental data will require doing
a large number of simulations.
• Parameter estimation. The execution of simulation requires the values of
model parameters to be known. Large pathway models often possess many un-
known parameters which have to be estimated from the training data. A common
approach to parameter estimation is via optimizing the agreement between the
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model prediction and the training data. Since there are many unknown pa-
rameters, the induced search space will be high-dimensional and contain many
local minima. Hence one will have to use global methods such as evolutionary
strategies. In order to find a good solution, global methods often evaluate many
combinations of parameter values. An evaluation is done by simulating the whole
system and computing the error between the model prediction and the experi-
mental data. As a result, parameter estimation will require also doing a large
number of simulations. Further, if the population data with limited precision, as
mentioned above, is used as training data, even more simulations will be needed.
• Model analysis. Many kinds of model analysis require doing a large number
of simulations as well. A few examples will be reviewed in Section 2.5, includ-
ing global sensitivity analysis, perturbation optimization and population-based
analysis. Specifically, the global sensitivity analysis assesses the overall effects of
parameters on the model output by simultaneously perturbing all the parameters
within a parameter space. It often follows a Monte Carlo scheme: simulate the
system for a large number of combinations of parameter values and derive the
global sensitivities by statistically analyzing the simulation results. Perturbation
optimization aims to find the best perturbation to fulfill certain design goals such
as maximizing the production of a biochemical substance, while minimizing the
formation of undesirable byproducts. Due to the combinatorial nature of the
problem, the solution spaces of large models will contain a huge number of can-
didate perturbations. Consequently, similar to parameter estimation, finding the
best perturbation will require doing a large number of simulations.
CHAPTER 1. INTRODUCTION 6
1.2 Our Approach and Contributions
ODE models are prevalent for modeling biological pathways. However, as pointed out
above, carrying out model calibration and analysis on large pathways will require a
large number of simulations, which is very computational expensive. This motivates
our main goal, namely, to approximate the dynamics of systems of ODEs modeling
biological pathways.
In this thesis, we propose an approach by which one can approximate the ODE
dynamics as a dynamic Bayesian network (DBN) (Murphy, 2002). As a result, tasks
such as parameter estimation and global sensitivity analysis can be efficiently carried
out through standard Bayesian inference techniques. Our techniques can be adapted
to modeling formalisms such as hybrid functional Petri nets (Matsuno et al., 2003b) as
well.
1.2.1 The Approximation Technique
Given a system of ODEs, we assume that the dynamics is of interest only for a finite
time horizon and that the states of the system are to be observed only at a finite set
of discrete time points. Next we partition the range of each variable into a finite set
of intervals according to the assumed observation precision. We also discretize the
range of each parameter into a finite set of intervals. The initial values as well as the
parameters of the ODE system are assumed as distributions (usually uniform) over the
intervals defined by the discretization. For unknown parameters, we assume they are
uniformly distributed within their ranges.
After fixing the discretization and the distribution of initial states, we sample the
initial states of the system (i.e. a vector which assigns an initial value for each variable
and parameter) and generate a trajectory by numerical integration for each of the
sampled initial states. The key idea is that a sufficiently large set of such trajectories
is a good approximation of the dynamics defined by the ODEs system.
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The second key idea is that this set of trajectories or rather, the statistical properties
of these trajectories can be compactly stored in the form of a dynamic Bayesian network
(DBN) (Murphy, 2002) by exploiting the network structure of the pathway and simple
counting. As a result, by querying this DBN representation using standard inferencing
techniques one can analyze, in a probabilistic and approximate fashion, the dynamics
defined by the system of ODEs.
The construction process consists of two steps: (i) derive the underlying graph of
the DBN approximation by exploiting the structure of the ODEs, (ii) fill up the entries
of the conditional probability tables associated with the nodes of the DBN by sampling
the prior distributions, performing numerical integration for each sample, discretiz-
ing generated trajectories by the predefined intervals and computing the conditional
probabilities by simple counting.
Since the trajectories are grouped together through the discretization, our method
bridges the gap between the accuracy of the results obtained by ODE simulation and
the limited precision of experimental data used for model development. In addition,
the approximation represents the dependencies between the variables more explicitly in
the graph structure of the underlying DBN. More crucially, many interesting pathway
properties can be analyzed efficiently through standard Bayesian inference techniques,
instead of resorting to large scale numerical simulations. Here we present a few exam-
ples informally:
• Probabilistic inference. Given initial state as evidence, the Bayesian inference
technique called the Factored Frontier algorithm (Murphy and Weiss, 2001) can
be used to approximately but efficiently infer the marginal probability of each
species’ concentration at a given time point.
• Parameter estimation. Our approximation approach enables a two-stage pa-
rameter estimation method. In the first stage, we infer the marginal distributions
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of the species at different points in the DBN. The mean of each marginal distri-
bution are computed in order to compare with the time serials training data.
Standard optimization methods are used for searching in the discretized param-
eter space. The result of this first stage is a maximum likelihood estimate of a
combination of intervals of parameter values. In the second stage, by treating the
resulting combination of intervals of parameter values from the first stage as the
(drastically reduced) search space, one can further estimate the real values for
unknown parameters. The second stage results in parameters with a finer granu-
larity, which can be used to perform simulations and analysis requiring perturbing
the initial concentrations.
• Global sensitivity analysis. We can use DBN approximation to perform global
sensitivity analysis. Monte Carlo samples are drawn from the discretized param-
eter space. Simulation trajectories will be approximated by the mean of marginal
distributions inferred from the DBN by supplying the selected combination of
intervals of parameter values as evidence.
Admittedly, there is a one-time computational cost incurred to construct the DBN
approximation. But this cost can be easily amortized by performing multiple analy-
sis tasks using the DBN approximation. This will be demonstrated by studying two
existing pathway taken from Brown et al. (2004) and Goldbeter and Pourquie (2008)
and a “live” pathway called complement system in collaboration with biologists and
clinicians (Liu et al., 2011).
Our work is, in spirit, related to the discretized approximations presented in Calder
et al. (2006b,c); Ciocchetta et al. (2009) that are based on stochastic modeling for-
malisms such as PEPA (Hillston, 1996) and the modeling language PRISM (Kwiatkowska
et al., 2002). In these works, the dynamics of a process-algebra-based description of
a biological pathway is given in terms of a Continuous Time Markov Chain (CTMC)
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which is then discretized using the notion of levels to ease analysis. Apart from the
fact that our starting point is a system of ODEs, a crucial additional step that we
take is to exploit the structure of the pathway to factor the dynamics into a DBN. We
then perform analysis tasks on this more compact representation. In a similar vein,
our model is more compact than the graphical model of a network of non-homogenous
Markov chains studied in Nodelman et al. (2002).
For sure, our DBN approximation may be viewed as a factored Markov chain. In
this sense, a crucial component of our construction mirrors the technique of factoring
a Hidden Markov Model (HMM) as a DBN by decomposing a system state into its
constituent variables (Russell and Norvig, 2003). This connection leads us to believe
that the techniques proposed in Langmead et al. (2006a), as well as the verification
techniques reported in Clarke et al. (2008); Heath et al. (2008) can be adapted to
our setting. Analyzing CTMC models PEPA requires stochastic simulations that are
often computationally intensive Geisweiller et al. (2008). We note however the DBN
approximation is a probabilistic graphical model and hence we do not have to resort
to stochastic simulations. The inferencing algorithm we use (the Factored Frontier
algorithm (Murphy and Weiss, 2001)), in one sweep, gathers information about the
statistical properties of the family of trajectories encoded by the DBN approximation.
1.2.2 The Biological Contributions
The complement system is key to innate immunity and its activation is necessary for
the clearance of bacteria and apoptotic cells. However, insufficient or excessive com-
plement activation will lead to immune-related diseases. It is so far unknown how the
complement activity is up- or down- regulated and what the associated pathophysiolog-
ical mechanisms are. To quantitatively understand the modulatory mechanisms of the
complement system, we built a computational model involving the enhancement and
suppression mechanisms that regulate complement activity. Our model has been added
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to the BioModels database (ID: BIOMD0000000303). It consists of 42 species, 45 reac-
tions and 85 kinetic parameters with 71 of the parameters being unknown. The ODE
model is accompanied by a DBN as a probabilistic approximation of the ODE dynam-
ics. We used the DBN approximation to perform parameter estimation and sensitivity
analysis. Our combined computational and experimental study highlights the impor-
tance of infection-mediated microenvironmental perturbations, which alter the pH and
calcium levels. It also reveals that the inhibitor, C4BP induces differential inhibition on
the classical and lectin complement pathways and acts mainly by facilitating the decay
of the C3 convertase. These predictions were validated empirically. Thus our results
help to elucidate the regulatory mechanisms of the complement system and potentially
contribute to the development of complement-based immunomodulation therapies.
1.3 Outline
The rest of this thesis is organized as follows.
In Chapter 2 we give an overview of the current state of pathway modeling. We
present the background knowledge on biological pathways and discuss the process of
pathway modeling. We then review several formalisms that are commonly used to
model the pathway dynamics. We also describe some existing methods for parameter
estimation. Further, we present two useful model analysis techniques.
Chapters 3-5 form the core of the work, in which we present our probabilistic
approximation technique. After introducing the preliminaries in Chapter 3, we describe
our method for constructing the DBN approximation in Chapter section 4. In Chapter
5, we present techniques for performing tasks such as basic inferencing, parameter
estimation and global sensitivity analysis using the DBN approximation.
Chapter 6 establishes the applicability of probabilistic approximation techniques.
In Section 6.1 and Section 6.2 we present two case studies on the EGF-NGF signaling
pathway and the segmentation clock pathway respectively. We compare the efficiency of
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our method to conventional approaches for parameter estimation and global sensitivity
analysis. We also compare the performance of different sampling techniques and the
accuracies of approximations constructed using different discretization schemes. In
Section 6.3 we further demonstrate the usefulness of our method by an integrated
computational and experimental study of the human complement system. We present
our model constructed for the complement regulatory mechanisms. We also discuss the
computational and experimental results as well as the biological insights we gained.
Finally, in Chapter 7, we summarize the main results and discuss the future lines
of research.
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Chapter 2
Background and Related Work
In this chapter, we discuss the current state of bio-pathway modeling. After presenting
the background knowledge, we review the processes of model construction, calibration,
validation and analysis. We then discuss several formalisms that are used to capture
pathway dynamics. Next we review some existing methods for model calibration. Fi-
nally, we present two useful model analysis techniques, namely, sensitivity analysis, and
perturbation optimization.
2.1 Biological Pathways
Cellular processes are driven by networks of biochemical reactions, termed biologi-
cal pathways. Biological pathways can be loosely classified into signaling pathways,
metabolic pathways, and gene regulatory networks. Specifically:
• Signaling pathways. Signaling pathways describe how cells sense changes or
stimuli in their environment, pass the received signals messages via cascades of
biochemical reactions, and respond by modifying their metabolisms, transcrip-
tional activities or cell fates. The chief actors in signaling pathways are proteins
such as receptors, kinases, and transcription factors.
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• Metabolic pathways. Metabolic pathways consist of chemical reactions in-
volved in metabolism, through which cells acquire energy for survival and repro-
duction. The major players in metabolic pathways are chemical compounds such
as glucose, adenosine diphosphate (ADP), and adenosine triphosphate (ATP).
• Gene regulatory networks The expression of a gene is highly regulated by
transcription factors synthesized from other genes. Gene regulatory networks
often abstract the reactions involved in the processes of DNA transcription, RNA
translation, and post translation modification of proteins and depict the indirect
regulatory relationship among genes in the cell.
The three classes of biological pathways describe different aspects of cellular pro-
cesses. Cells rely on their tight cooperation to achieve proper functioning. In this
thesis, we focus mainly on signaling pathways, though our techniques can be applied
to metabolic pathways and gene regulatory networks as well.
Cellular processes are dynamic. In other words, the number of biomolecules such
as protein concentrations, metabolite concentrations, and gene expression levels are
changing over time. Hence the biological pathways can be viewed as dynamical sys-
tems, whose state is defined as a snapshot the quantity of involved species at a time
point. The dynamics of biological pathways are crucial for cellular functions. A re-
markable example is the biological pathway controlling the circadian rhythm (biological
clock). The built-in circadian rhythm in our body regulates the daily cycles of many
physiological processes such as the sleep-wake cycle and feeding rhythms (Bell-Pedersen
et al., 2005). It arises from the oscillatory expression of a number of genes. The time
profile of expression level of some related genes are shown in Figure 2.1. It can be ob-
served that the periods of the oscillations roughly equal to 24 hours. The oscillations of
gene expression are governed by the underlying signaling pathways. Figure 2.2 depicts
the Drosophila circadian rhythm pathway proposed by Matsuno et al. (2003a). The
oscillator is composed of interlocking feedback loops that regulate the concentrations of
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transcription factors. These transcription factors further control the expression of many
other genes, as the output of the oscillator, resulting in behavioral and physiological
rhythms.
TOC1 CCA1 PRR9
Figure 2.1: The expression of circadian rhythm related genes. This figure is reproduced
from James et al. (2008).
There are hundreds of biological pathways governing various cellular processes rang-
ing from cell cycle to cell death. Some of the heavily studied signaling pathways are
summarized in Figure 2.3 (Lodish, 2003). For instance, apoptosis pathways induce the
programmed cell death (Spencer et al., 2009). EGF/NGF signaling pathway determines
the cell differentiation or cell proliferation (Kholodenko, 2007). Wnt signaling pathway
governs the expression of developmental genes (Logan and Nusse, 2004). NF-κB path-
way regulates inflammatory responses (Egan and Toruner, 2006). Similar to circadian
rhythm pathway, these pathways often consist of many species and multiple feedback
loops. Consequently, it is very difficult to predict the dynamical behavior of the system
based on intuition. Hence one will have to resort to computational modeling.
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Figure 2.2: The Drosophila circadian rhythm pathway model. This figure is reproduced
from Matsuno et al. (2003a).
2.2 Pathway Modeling
To study the complex dynamics of biological pathways, a variety of computational
models have been proposed in recent years, ranging from qualitative models that focus
on the generic properties of biological networks (Papin and Palsson, 2004; Helikar
et al., 2008) to quantitative models that can simulate the time course of biological
pathways under various conditions (Vaseghi et al., 2001). The choice of a modeling
formalism depends on the goals of the modeling effort as well as the biological context.
For instance, the Boolean network is a frequently used qualitative formalism (Fisher
et al., 2007; Thakar et al., 2007), while typical quantitative formalisms are ordinary
differential equations (ODEs) (Aldridge et al., 2006), Petri nets (Matsuno et al., 2003a),
performance evaluation process algebra (PEPA) (Hillston, 1996), PRSIM (Kwiatkowska
et al., 2002), and κ (Danos et al., 2007). On what follows, we focus mainly on the
quantitative model.
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Figure 2.3: Overview of some of the important signaling pathways (Lodish, 2003)
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Regardless of the type of quantitative model used, a typical computational modeling
effort involves the following steps:
1. Model construction. Decide the model scope and build the model structure
by capturing the current knowledge of the pathway.
2. Model calibration. Divide the available experimental observations of the path-
way dynamics into two parts -training data and test data- and calibrate the model
parameters so that model predictions are able to reproduce the observations in
the training data.
3. Model validation. Test the capability of a calibrated model by evaluating the
fitness of model predictions to the test data. (The test and training data can be
of different kinds. The key point is that the model must be validated using data
that was not used for training it.)
4. Model analysis. Perform various kinds of analyses on the validated model
in order to gain biological insights, reveal the network properties, and generate
hypotheses.
In Step 1, an initial model can be constructed based on the literature as well as
the pathway databases such as Reactome (Joshi-Tope et al., 2005). In this step one
often requires the guidance of biologists. In Steps 2 and 3, the experimental data
can include both quantitative and qualitative measurements. However, quantitative
measurements of the time serials of species concentration are preferred for Step 2, as
they may provide more constraints to the model. The calibration process of Step 2 is
also known as parameter estimation, which will be discussed in detail in Section 2.4.
If the model predictions fit the training data in Step 2 and can be validated by test
data in Step 3, we trust the model to be reasonably reliable and use it as a basis for
analysis in Step 4. Simulation is a useful tool for performing model analysis. Through
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simulations, one can observe the time profile of species or system behavior that have
not been measured, or even can not be measured via current technology. Further, one
can simulate the system under different conditions by modifying the model structure,
initial condition or kinetic parameters. In this manner, one can carry out “what if?”
experiments suggested by biologists through local modifications of the model. One can
also apply techniques such as sensitivity, perturbation and population-based analysis
etc. The corresponding wet-lab experiments will be, in general, very time consuming
and expensive. They might not even be possible due to the unavailability of the needed
bio-markers. In this sense, the model and its analysis techniques can serve as an
additional tool, which biologists can use to perform extensive in silico experiments
quickly and cheaply, in order to advance biological knowledge.
It is worth noting that, in practice, the process of model development may not
simply follow a linear order of the above steps but often involve a cyclic workflow. For
Step 2, if one is unable to find proper parameters so that the fitness between model
predictions generated using the estimated parameters and training data is acceptable,
one will have to go back to Step 1 and refine the model structure by adding further
structural details which had been left out. Similarly, for Step 3, if the model cannot be
validated, one could go back to Step 1 and improve the model. In addition, one could
also try to acquire more experimental data concerning the structure and dynamics.
But what if we still can not pass Step 2 and Step 3, when we already exhausted the
resources? Interestingly, the failure in Step 2 or Step 3 might become a seedbed for
generating hypotheses. By analyzing the mismatch between model prediction and the
data, one may propose missing links, cross-talks, feedback loops, etc. of the pathway,
which can guide biologists in their further investigations.
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2.3 Modeling Formalisms
In this section, we present some of the well-established quantitative models for captur-
ing and analyzing pathway dynamics.
2.3.1 Ordinary Differential Equations
Modeling biological pathway dynamics with ordinary differential equations (ODEs) is
a major approach in current systems biology research (Materi and Wishart, 2007). The
idea is to describe biochemical reactions such as biomolecular association and enzyme
catalytic modification, using equations derived from physicochemical theories (Aldridge
et al., 2006).
In the context of biological pathway modeling, one often uses t to denote time and
x to denote the concentration level of individual biomolecular species. As a result,
the function x(t) will depict the time profile of species x while its derivative dxdt will
represent the rate of change of x.
A biological pathway usually involves many species and can be viewed as a network
of biochemical reactions. The rate of change of the concentration of each species in
the network will be determined by the rates of reactions that produce or consume
this species. Based on suitable assumptions, physical and chemical laws (such as mass
action law, Michaelis-Menten law and power law) can be applied to calculating the
reaction rates from the concentrations of their participating species. For example, under
assumption the species are spatially homogeneous, the mass action law (Guldberg and
Waage, 1879) states that the rate of a reaction is proportional to the concentrations







whereA andB are substrates, AB denotes the formed complex, and v1 and v2 represents
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the association rate and dissociation rate respectively. By the mass action law, we have:
v1 = k1 ·A ·B
v2 = k2 ·AB
where k1 and k2 are so-called rate constants.
The choice of a kinetics law depends on the nature of the reaction to be described.
For example, the enzyme catalyzed reactions such as protein phosphorylation are often
modeled using Michaelis-Menten equations. Equation 2.2 shows the reaction scheme
of a typical enzyme catalyzed reaction.
S + E
v→ P + E (2.2)
where S denotes substrate, E denotes enzyme, P denotes product and v denotes the
reaction rate. By assuming that S  E, v can be expressed by the Michaelis-Menten
equation as follows:
v =
k · S · E
Km + S
(2.3)
where k and Km are constants.
Once we write down rate equations for all reactions in a network, the rate of change
of each species can then be derived by summing all reaction rates that produce this
species and subtracting all reaction rates that consume this species. As reaction rates
are calculated from the concentrations of species and kinetic constants, the rate of
change of a species xi can be written as a function fi, typically nonlinear, involving
variables from {x1, x2, . . . , xn} and parameters (rate constants) from {p1, p2, . . . , pm}.










= −k1 ·A ·B + k2 ·AB
dB
dt
= −k1 ·A ·B + k2 ·AB
dAB
dt
= k1 ·A ·B − k2 ·AB
dS
dt





k · S ·AB
Km + S
Figure 2.4: The ODE model of a small pathway.
where the vector x(t) represents the concentrations of species at time t, and the vector
p refer to the rate constants of the reactions.
Example Consider a small pathway which links the assembly process described in
Equation and the catalysis process described in Equation 2.2 by setting AB to be E
(see Figure 2.4, left panel). The ODE model of this pathway is shown in the right panel
of Figure 2.4.
Given the initial values of the variables and parameters (initial condition) and suit-
able continuity assumptions, a system of ODEs will have a unique solution specifying
how the system will evolve over time (Hirsch et al., 2004). Hence models defined with
ODEs can be used to produce predictions of system behavior by solving this initial
value problem. However, the ODE systems describing biological pathway dynamics
are usually high-dimensional and nonlinear. Hence they will not admit closed form
solutions. Instead, one will have to resort to numerical integration methods to get
approximate solutions. For example, finite difference methods numerically approxi-
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then a reasonable approximation of the derivative would be
x′(t) ≈ x(t+ δ)− x(t)
δ
(2.6)
for a sufficient small δ. Since x′(t) is known, by giving initial condition x(0), we can
iteratively compute x(t) for any t as follows:
x(t+ δ) = x(t) + δ · x′(t) (2.7)
This is the so-called Euler’s Method. To achieve high accuracy, it requires δ to be
very small. Accordingly, for a fixed T , the maximal time point of interest, the required
number of simulation steps T/δ will be a large number. As a result, solving large
ODE system will be computationally intensive. In the past decades, many advanced
ODE solvers have been developed to improve the performance of numerical integration.
Different solvers are usually specialized for better performance on some classes of ODEs.
To deal with the ODE systems of biological pathway models, methods such as Runge-
Kutta (Hindmarsh, 1983) and LSODA (Petzold, 1983) have been used. For example, let
x′(t) = f(x(t)) the formula of the fourth order Runge-Kutta (RK4) will be as follows:
A1 = f(x(t))








A4 = f(x(t) + δ ·A1)
x(t+ δ) = x(t) +
1
6
· δ · (A1 + 2A2 + 2A3 +A4)
However, it remains computationally expensive for solving large or stiff1 ODE systems,
1A system of ODEs is said to be stiff if explicit numerical methods such as Runge-Kutta require
very small step size to achieve the desired accuracy.
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which are often unfortunately induced by biological pathway models.
Simplifications
To reduce the complexity of ODE-based pathway models, simplification methods have
been proposed based on certain assumptions. First of all, during the model design pro-
cess, assumptions can be made about the model scope. Species will be included in the
model only if they are necessary for the target analysis. It is important to determine
the degree of details so that the model constructed contains as few species and param-
eters as possible, while meeting the design goals. For example, nuclear localization of
the transcriptional activator Nuclear factor κB (NF-κB) is controlled in mammalian
cells by NF-κB inhibitor protein IκB, which has three isoforms: IκBα, IκBβ, and IκB.
Hoffmann et al. (2002) found that IκBα is responsible for strong negative feedback that
allows for a fast turn-off of the NF-κB response, whereas IκBβ and IκB function to
reduce the system’s oscillatory potential and stabilize NF-κB responses during longer
stimulations (Hoffmann et al., 2002). Thus, their model includes all the three isoforms
with corresponding reactions in order to understand their different roles. On other
hand, in the model built by Cho et al. (2003), the three isoforms are treated as one
protein since they only aim to analyze the sensitivity of parameters in TNFα-mediated
NF-κB pathway and this will not be effected by the variation of IκB isoforms.
Secondly, one can simplify the ODE model by abstractions. In fact, the Michaelis-
Metnten equation is obtained by abstracting mass action kinetics. By assuming that
the concentration of substrate is much larger than the concentration of enzyme, it
eliminates the unnecessary intermediate products and replace the original parameters
that are hard to measure by fewer measurable ones (Klipp et al., 2005). The idea of
Michaelis-Menten approximation has been extended by Schmidt et al. (2008) to deal
with all rate expressions that can be written as a fraction between two polynomials.
For instance, after applying their algorithm, complex rate equations such as the one
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appear in (Teusink, 2000):
voriginal =




1 + [F16bP ]KF16bP +
[DHAP ]
KDHAP
+ [GAP ]KGAP +
[F16bP ][GAP ]
KF16bPKGAP
+ [DHAP ][GAP ]KDHAPKGAP
(2.8)






In the recent years, ODE based modeling has played a dominant role in systems bi-
ology. Numerous insights have been gained through simulating and analyzing ODE
models. For example, Gallego et al. (2006) found that tau has an opposite role to
what we believed in circadian rhythms. Sasagawa et al. (2005) showed that transient
ERK activation depends on rapid increases of EGF and NGF but not on their final
concentrations, whereas sustained ERK activation depends on the final concentration
of NGF but not on the temporal rate of increase. Spencer et al. (2009) discovered that
differences in the levels of proteins regulating receptor-mediated apoptosis are the pri-
mary causes of cell-to-cell variability in the timing and probability of death in human
cell lines. Basak et al. (2007) showed that mutant cells with altered balances between
canonical and noncanonical IkB proteins may exhibit inappropriate inflammatory gene
expression in response to developmental signals. With help of ODE models, all the
above example studies generated very interesting and important hypotheses, which
were confirmed or supported by further verification wet-lab experiments.
2.3.2 Petri Nets
Petri nets, originally proposed by Carl Adam Petri in 1962 (Petri, 1962), is a mathemat-
ical model for the representation and analysis of concurrent processes. It graphically
depicts the structure of a concurrent system as a directed bipartite graph with annota-
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tions. A Petri net consists of three primitive elements - places, transitions and directed
arcs. In the context of bio-pathway modeling, places often denote species while transi-
tions represent the biochemical reactions. The places are connected to the transitions
(and vice versa) via directed arcs to form a network.
In the graphical representation, places are drawn as circles, transitions are denoted
by bars or boxes, and arcs are labeled with their weights (positive integers), where
a k-weighted can be interpreted as the set of k parallel arcs. The input places of a
transition are the places from which an arc runs to it; its output places are those to
which an arc runs from it.
Places may contain any nonnegative number of tokens, which are represented as
block dots inside the corresponding place. A distribution of tokens over the places
of a net is called a marking. Transitions can fire (i.e. execute) if they are enabled,
which means there are enough tokens in every input place. When a transition fires, it
consumes a number of tokens from each of its input places, and produces a numbers of
tokens on each of its output places.
Example Figure 2.5 shows a Petri net model of the enzyme catalysis system. In this
example, the places E, S, P denote the enzyme, product and substrate respectively.
The transition T represents the enzyme catalyzed reaction. The number of tokens
depicts the concentration level of a species. The initial marking is shown in the left
panel of Figure 2.5. Transition T is enabled. After firing T once, the resulting marking
is shown in the right panel of Figure 2.5.
Petri nets support a number of qualitative analysis for checking the topological
properties of the network. To enable quantitative simulation and analysis, various
types of Petri nets have been proposed by extending the original Petri net, such as
timed Petri nets, stochastic Petri nets, hybrid Petri nets, and functional Petri nets
(Reisig and Rozenberg, 1998). Many of them have been deployed for simulating the
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Figure 2.5: A Petri net example of the enzyme catalysis system.
dynamics of biological pathways. For instance, Ruths et al. (2008) studied a MAPK and
AKT signaling network downstream from EGFR in two breast tumor cell lines using
stochastic Petri net. Bonzanni et al. (2009) used a coarse-grained quantitative Petri
net to mimic the multicelluar process of Caenorhabditis elegans vulval development.
Additional Petri net models of biological pathways can be found in Chen and Hofestaedt
(2003), Voss et al. (2003), Heiner et al. (2003), Koch et al. (2005), and Lee et al. (2006).
The Petri net-based approaches used in systems biology has been reviewed in Koch
et al. (2010). Among various types of Petri nets, the Hybrid Functional Petri net
(HFPN) (Matsuno et al., 2003a) is an useful approach that can capture both the discrete
and continuous features of pathway dynamics. This variant has been implemented in a
software tool called Cell Illustrator (Doi et al., 2003; Nagasaki et al., 2010), which has
been used to model and analyze a number of biological pathways (Tasaki et al., 2010;
Do et al., 2010; Li et al., 2009; Sato et al., 2009).
The HPFN inherits the notations of the hybrid Petri net (David and Alla, 1987)
and the functional Petri net (Valk, 1978) and adds more functionality. As it can deal
with both discrete and continuous components, two kinds of places and transitions are
used (the graphical notation are shown in Figure 2.6).
A discrete place is the same as a place in Petri net, i.e. it can only hold integer








Figure 2.6: HFPN notations.
number of tokens. In other hand, a continuous place can hold non-negative real num-
bers as its content. For transitions, a discrete transition can only fire when its firing
conditions are satisfied for certain duration of time, denoted by a delay function. In
contrast, a continuous transition fires continuously in and its firing speed is given as a
firing function of values at particular places in the model. The firing speed describes
the consumption rate of its input places and the production rate of its output places.
In addition, there are two more kinds of arcs - the inhibitory arc and the test arc
(Figure 2.6). An inhibitory arc with weight r enables the transition to fire only if the
content of the place at the source of the arc is less than or equal to r. A test arc,
behaves like a normal arc, except that it does not consume any content of the place
at the source of the arc when it fires. Furthermore, there are also some restrictions
for connection. For example, a discrete place cannot connect to a discrete place via a
continuous transition. Test and inhibitory arcs are restricted to only connect incoming
places to transitions as they both involve satisfying a precondition.
Example A HFPN model of the enzyme catalysis system is shown in Figure 2.7. In
this example, the markings of the continuous places E, P , and S denote concentrations
of the enzyme, product and substrate. The formula of the transition T specifies the
rate equation of the enzyme catalyzed reaction. Let k = 0.01, Km = 10, after firing T
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Figure 2.7: A Petri net example of the enzyme catalysis system.
Notice that the execution process of this HFPN is equivalent to solving the following
ODE system using the Euler’s method.
dS
dt










In this manner, any ODE-based pathway model can be translated into a HFPN
model, which only contains continuous places and transitions as well as the arcs. Hence,
the HFPN can be viewed as an extension of the ODE formulism with discrete aspects.
2.3.3 Stochastic Models
Deterministic models such as ODE and HFPN assume that the concentrations of in-
volved species are sufficiently high and the molecules are uniformly distributed in cel-
lular compartments. However, when the concentrations of species are low (e.g. dozens
or hundreds), the variability of reaction processes will increase and may significantly
influence the systems behavior. For example, the development of phage λ infected E.
CHAPTER 2. BACKGROUND AND RELATED WORK 29
coli cells (Arkin et al., 1998) is determined by a switch point. Two proteins with low
concentration levels competitively control this switch. As a result, the developmental
outcome is probabilistic and cannot be captured by conventional deterministic models.
In such cases, stochastic modeling will be required.
In stochastic modeling, one often described the state of the system by a vector
X(t) = (X1(t), X2(t), . . . , XN (t)), where Xi(t) is a nonnegative integer which expresses
the number of molecules of species i at time t. Starting from an initial state X(0) = x0,
X(t) can evolve its value when a reaction takes place, which is a stochastic event.
By modeling the probabilities of occurrences of reactions, the Chemical Master
Equation (CME) can be used to capture the evolution of X(t) (de Jong, 2002). How-
ever, its size grows exponentially as the number of species increase and does not have
analytical solutions. In order to efficiently simulate CME, Gillespie (1977) developed
a stochastic simulation algorithm. Instead of solving for the individual state transition
probabilities, the Gillespie’s algorithm generates trajectories of X(t). The statistical
properties of the ensemble of the trajectories generated by the algorithm can yield -
in principle- accurate information about the global stochastic dynamics as predicted
by the CME. Since the Gillespie’s algorithm is computationally expensive in terms of
time, many improvements have been proposed such as the τ -leaping approximation
(Wilkinson, 2006).
Note that if the value of Xi(t) represent a discrete concentration level, X(t) can be
viewed as a Continuous Time Markov Chain (CTMC) (Ross, 2002). Hence the idea of
Gillespie’s algorithm can also been adapted by many stochastic modeling formalisms
such as PEPA (Hillston, 1996), PRISM (Kwiatkowska et al., 2002), and κ (Danos et al.,
2007), which are modeling languages describing the system’s dynamics in terms of a
CTMC.
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PEPA
PEPA (Hillston, 1996) is a stochastic process algebra originally designed to modeling
computer and communication systems. Recently, it has also been applied to model-
ing biological pathways (Calder et al., 2006b,c; Ciocchetta et al., 2009). The PEPA
language have five combinators, prefix, choice, cooperation, hiding and constant.
• Prefix (α, r).P implies that after the component has performed activity α at rate
r, it behaves as component P .
• Choice P1 + P2 sets up a competition between two possible alternatives.
• Cooperation P1 BC
L
P2 describes the synchronization of P1 and P2 over the ac-
tivities in the cooperation set L.
• Hiding P/L is a component behaves like P except that any activities of types
within L are hidden.
• Constant A def= P is a component whose meaning is given by a defining equation.
Example Figure 2.8 shows a PEPA model of a small network presented in Calder
et al. (2006a). Species A, B, and C are associated with distinct PEPA components.
The concentrations of species are discretized into high (H) and low (L) levels. A
stochastic rate is associated with each event in this process algebra.
A PEPA model can be mapped to a CTMC and can be simulated and analyzed
using stochastic simulation tools such as Dizzy (Ramsey et al., 2005). If we use numbers
of molecules instead of discrete concentration levels, a PEPA model can be mapped to a
CME that can be simulated using Gillespie’s algorithm. Interestingly, Geisweiller et al.
(2008) showed that an ODE model can also be derived from a PEPA representation.
Recently, an extension of PEPA called Bio-PEPA has been proposed in order to handle
more features of biological systems. Bio-PEPA is promising to support different kinds








= (b a, β).AH + (c a, γ).AH
AH
def
= (ab c, α).AL
BL
def
= (c b, δ).BH
BH
def
= (ab c, α).BL + (b a, β).BL
CL
def
= (ab c, α).CH
CH
def
= (c a, γ).CL + (c b, δ).CL
(AH BC{ab c,b a}BH) BC{ab c,c a,c b}CL
Figure 2.8: A PEPA example of a small biopathway (Calder et al., 2006a).
of analysis, including stochastic simulation, ODE-based analysis, and PRISM-based
model checking.
PRISM
Probabilistic modeling checking is a formal verification technique for analyzing the
properties of stochastic systems (Kwiatkowska et al., 2007). PRISM (Kwiatkowska
et al., 2002) is the state of the art tool for carrying out probabilistic model checking
on CTMC models and has been applied to systems from various domains. Recently, it
has been used to analyze biological pathways (Kwiatkowska and Heath, 2009) such as
the ERK (Calder et al., 2005), and FGF signaling pathways (Kwiatkowska et al., 2006;
Heath et al., 2008).
The PRISM modeling language describes stochastic systems using variables and
modules. In the context of biopathway modeling, the values of variables are nonnegative
integer representing the discrete concentration levels of species. A module contains a
number of variables and specifies then updating rules for them. Each rule describes how
the values of variables involved in a biochemical reaction are updated under particular
conditions. Each update is also assigned a rate describing the probability of occurring.
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Example Figure 2.9 shows an example of the PRISM model of the reversible binding
process presented in equation 2.1.
ctmc 
const double k1 = 0.1; 
const double k2 = 0.01; 
module A 
 A : [0..5] init 5; 
 [bind] (A>0) -> A* k1 : (A’ = A - 1);  
endmodlue 
module A 
 A : [0..5] init 5; 
 [bind] (B>0) -> B* k1 : (B’ = B - 1);  
endmodlue 
module AB 
 AB : [0..5] init 0; 
 [bind] (AB < 5) -> k2 : (AB’ = AB + 1);  
endmodlue 
module RATES 
 [bind] true -> k1 : true; 
 [bind] true -> k2 : true; 
endmodlue 
Figure 2.9: A PRISM example of the binding process A+B 
 AB.
The main feature of PRISM-based modeling is that many interesting and complex
properties of the system can be verified via probabilistic model checking. PRISM allows
properties to be specified using various temporal logics such as Linear Temporal Logic
(LTL) (Pnueli, 1977), Probabilistic Continuous Temporal Logic (PCTL) (Hansson and
Jonsson, 1994) and Continuous Stochastic Logic (CSL) (Aziz et al., 2000). For instance,
a property can be written as the following logical formula:
(A < 2)⇒ P>0.2[trueU[0,4](AB = 3)] (2.10)
This property can be read as “if protein A’s concentration level is lower than 2, then the
probability of the complex AB’s concentration level being 3 within the next 4 seconds
is greater than 0.2”.
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A common limitation of the current stochastic models is scalability. As stochastic
simulations are computational intensive, the computations may become intractable
when analyzing large pathways. For instance, it has been reported by Calder et al.
(2005) that modeling checking an PRISM model of the ERK pathway, which consists
of only 11 species, with additional inhibition reactions, required the computational
power of a grid of over 90 computers.
2.4 Model Calibration
As discussed in previous section, many of the quantitative formalisms will induce a
large number of parameters. Usually, only a few of them are available in literature or
can be directly measured experimentally. Most of their values will be unknown. Thus,
one often has to estimate the values of unknown parameters from experimental data. In
this section, we focus on model calibration in the context of deterministic formalisms
such as ODEs and Petri nets, since stochastic models often assume parameters are
known and very little has been done for calibrating them.
The goal of model calibration is to estimate unknown parameter so that the model
can reproduce the experimental observations. Hence a common approach of parameter
estimation is to optimize the agreement between the model prediction and available
experimental data. In this manner, parameter estimation can be formulated as an
optimization problem with differential algebraic constraints. Typically, the goodness-
of-fit of a parameter combination is evaluated by the following objective function, which





ωi(xi,j − yi,j(p))2 (2.11)
where p is the parameter set being tested, xi,j is the experimental observation of
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the concentration of species xi at time point j, yi,j(p) is the corresponding prediction
generated using p, and ωi is the normalization factor for xi which is usually the inverse
of the maximum value of xi.
In order to find the parameter set popt that has the minimum objective value, a
common scheme of optimization algorithms is to repeatedly execute two steps: (1)
make guesses regarding the values of the parameters; (2) evaluate the goodness-of-fit
of the guesses. For step (1), guesses may be generated randomly in the first round but
later guesses are usually made based on the results of previous rounds. For step (2), to
get the value of yi,j in equation 2.11, one will have to simulate the ODE system upto the
maximum time point of the experimental observations. Obtaining the optimal solution
often requires repeated executions of these two steps. Thus, the parameter estimation
process will often be computationally intensive.
To improve the performance of parameter estimation, a critical issue to be addressed
is how to make “clever” guesses based on guesses that have been evaluated. In other
words, how to traverse the solution space so that the optimal solution can be found
as fast as possible? The traversing process is also known as searching, which is the
major distinguishing feature of the parameter estimation algorithms. For instance, to
determine the next point in the solution space to search, the Steepest Descent (Fogel
et al., 1992) method will follow the direction of steepest descent on the hypersurface
of the objective function. The Levenberg-Marquardt (Levenberg, 2; Marquardt, 1963)
method combines this heuristic with the Newton methods. The Hooke and Jeeves (HJ)
method (Hooke and Jeeves, 1961; Swann, 1972) will remember the descent direction of
previous searches and suggest a new direction to search. These methods are classified
as the local methods. In practice, they converge quite fast. However, they suffer the
local minima problem (Moles et al., 2003) and often return suboptimal solutions with
bad quality.
On other hand, global methods in principle guarantee optimal solutions. Many
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global methods have been proposed based on a variety of heuristics inspired by nature.
For example, algorithms such as Genetic Algorithm (GA) (Back et al., 1997; Mitchell,
1995) and Evolutionary Strategy (ES) try to mimic evolution which is driven by repro-
duction and selection. The idea of ES is illustrated in Algorithm 1. Particle Swarm
Optimization (PSO) method developed by Kennedy and Eberhart (1995) is inspired by
a flock of birds or a school of fish searching for food. Benchmarking tests of the perfor-
mance of global methods on biological pathway models have been done by Moles et al.
(2003) and Fomekong-Nanfack et al. (2007). They separately showed that a variation
of ES called Stochastic Ranking Evolutionary Strategy (SRES) (Runarsson and Yao,
2000) outperform other commonly used global methods. Some recent works attempted
to improve SRES by either transforming the search space (Kleinstein et al., 2006) or
incorporating more heuristics such as Fisher information matrix analysis (Rodriguez-
Fernandez et al., 2006a,b). Although the resulting algorithms outperform others in
general cases, they might still fail to produce good results within acceptable time when
dealing with large signaling networks. A pragmatic strategy one may consider is to
optimize the standard parameter estimation algorithms using the network properties
of the particular biological pathways being studied. Such example can be found in
Birtwistle et al. (3) and Bentele et al. (2004).
As one of the difficulties of parameter estimation is due to the high dimensional-
ity of search space, Koh et al. (2005) proposed a decompositional approach that can
break down a large pathway model into smaller components by exploiting its structure.
As a result, estimating parameters within each component separately is allowed and
the computational cost is largely reduced. In this approach, components that share
common parts may have conflicting parameter estimations, as they are computed inde-
pendently. Thus, in a subsequent work (Koh et al., 2007), global consistency is achieved
by applying belief propagation techniques. Notice that not all the networks can be de-
composed into small components and decompositional approaches rely on other search
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begin
Initialize parent population Pµ = {p1, . . . ,pµ}
repeat
for i ← 1 to λ do
S ← Pµ
Randomly select parents pc1,pc2 ∈ Pµ
pnew ← Recombine(pc1,pc2)
pnew ← Mutate(pnew)
S ← S ∪ {pnew}
Sort(S)
Pµ ← Select first µ from S
end
until Stopping Criteria ;
end
Algorithm 1: (µ+ λ)-ES
methods to deal with single component. Further, the high cost of simulations remains
a major barrier. Another difficulty of parameter estimation is due to inherent uncer-
tainty of data. To deal with noisy data, probabilistic approaches that aim to estimate
the posterior distributions for parameters via Bayesian inference has been proposed
(Yoshida et al., 2008; Girolami, 2008; Koh et al., 2010a). Furthermore, experimental
data is often generated incrementally. When new data arrives, we may have to repeat
the whole process of parameter estimation which is very time consuming. A recent
work by Koh et al. (2010b) attempts to address this issue by representing the pathway
parameter estimates using probabilistic graphical models. As a result, parameter esti-




In general, sensitivity analysis is the study of how the variation in the input of a compu-
tational model affects, qualitatively or quantitatively, the output of the model(Saltelli,
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2008). Here the input can be defined as the initial state or parameters of the model
and the output can be defined to be the dynamical behavior of a network component
of interest. Besides enriching our understanding, sensitivity analysis is also a powerful
technique for a range of purposes that have been summarized by van Riel (2006) as
follows:
• Drug target selection (Cascante et al., 2002; Rullmann et al., 2005).
• Biomarker selection (de Pillis et al., 2005).
• Experiment design (Rodriguez-Fernandez et al., 2006c; Cho et al., 2003; Gadkar
et al., 2005b).
• Model reduction (Bentele et al., 2004).
• Robustness analysis (von Dassow et al., 2000; El-Samad et al., 2005).
Local sensitivity analysis
Local sensitivity analysis is a particular form of sensitivity analysis similar to metabolic
control analysis (Salter et al., 1994). It has been widely applied on models of biological
pathways ranging from metabolic pathways (van Stiphout et al., 2006) to signaling
pathways (Schoeberl et al., 2002). Specifically, the sensitivity coefficient sij is defined
as the normalized first order derivatives of the model output oi with respect to the









Here one often specify pj to be a rate constant or the initial concentration of a species
and oi as a quantity that assets a characteristic of the system response. For instance,
we can define oi to be the transient concentration of a particular species (usually the
endpoint of signal transduction) at a specific time point t (Birtwistle et al., 3). In
this case, the sensitivity sij will become time dependent and can be denoted as sij(t).
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One may then plot sij(t) and further investigate how the sensitivities evolve over time
(Gunawan and Doyle, 2006). Furthermore, depending on the dynamical properties of
the system being studied, many other characteristics of the output response have been
used, such as: the amplitude and time of the response peak, the duration of the response
(Schilling et al., 2009), the integration of the response curve (Swameye et al., 2003), the
amplitude, period and phase of oscillation (Schoeberl et al., 2002; van Stiphout et al.,
2006; Gunawan and Doyle, 2006), the steady-state levels (Feng and Rabitz, 2004), the
deviation from the observations (Cho et al., 2003; Zi et al., 2005; Zhang and Rundell,
2006), etc.
Given a parameter pj , the corresponding oi can be predicted by simulating the
model. Thus, centered difference approximation techniques (Gunawan et al., 2005) can











Local sensitivity analysis assesses the effects of perturbations within a small local re-
gion around a specific point in parameter space. In other words, the computed local
sensitivities rely on the actual values of model parameters. However, in practice, the
values of many parameters have to be estimated form noisy and limited value. It is
possible for local sensitivity analysis to draw different conclusions about the importance
of the same parameter based on different sets of estimated values. Furthermore, even
if all the parameters can be measured experimentally, changes in cellular environments
may induce extensive variations of model parameters that might lead to different local
sensitivities. Therefore, it is a good to do sensitivity analysis in a more global manner
by exploring the effects of perturbations within a large region of parameter space.
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Global sensitivity analysis
To overcome the limitations of traditional local sensitivity analysis methods, various
global methods have been recently applied on biological pathway models (Cho et al.,
2003; Zi et al., 2005; Bentele et al., 2004; Zhang and Rundell, 2006; Lu¨dtke et al.,
2008; Rodriguez-Fernandez and Banga, 2008). These methods assess the overall effects
of parameters on the model output by simultaneously perturbing all the parameters
within a parameter space. A common Monte Carlo scheme adopted by many of them
can be described as follows: (1) draw a representative number of samples from the
parameter space (2) simulate the system for each sampled combination of parameters
(3) derive the global sensitivities of parameters by a statistical or information theoretic
analysis of the simulation results.
In step (3), the global sensitivities are measured in different ways depending on
the method used. For instance, the partial rank correlation coefficient (PRCC) analy-
sis calculates the global sensitivities from the Pearson correlation coefficients between
model output and input parameters (Draper and Smith, 1981). The global sensitivi-
ties calculated by Bentele et al. (2004) is a weighted average of the local sensitivities
of sampled values of parameters, where the weights are determined by a Boltzmann
distribution function of the error between model simulation and experimental data.
Sobol’s method estimates the partial variances of the model output for input param-
eters and defines the global sensitivities as the ratio of the related partial variances
to the overall variance of the model output (Sobol, 2001). In Multi-parametric sensi-
tivity analysis (MPSA) (Cho et al., 2003), the sampled parameter sets are classified
into two classes based on the objective value of each sample, which measures the er-
ror between experimental data and prediction generated by selected parameters. The
global sensitivities are then evaluated as the Kolmogorov-Smirnov statistic Kirjavainen
et al. (2008) of cumulative frequency curves of the parameter values associated with
the two classes. There are also attempts of deriving global sensitivities via information
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theoretic analysis. For example, Lu¨dtke et al. (2008) treated the pathway system as
a ‘communication channel’ and quantified the associations between input parameters
and model output by decomposing their mutual information. More methods for global
sensitivity analysis have been reviewed in the book by Saltelli (2008).
Biological pathway models often contain many parameters, which lead to a high
dimensional parameter space. Hence step (1) of the above scheme will require a large
number of samples to explore the parameters space. Consequently, carrying out global
sensitivity analysis becomes computationally extremely expensive. To get around of
this, efficient sampling methods have been proposed. For instance, Latin hypercube
sampling (LHS) is a sampling method requiring fewer samples while guaranteeing that
individual parameter ranges are evenly covered. It has been adopted to improve MPSA
(Zi et al., 2005) and PRCC (Zhang and Rundell, 2006) analysis. Instead of random
sampling, heuristic sampling from optimization algorithms has been used for comput-
ing global sensitivities with certain special definition (Sahle et al., 2008). Furthermore,
Zhang and Rundell (2006) proposed to reuse the computational effort put during pa-
rameter estimation to improve the performance of global sensitivity analysis.
2.5.2 Perturbation Optimization
With a comprehensive understanding of cellular mechanisms, the modern technologies
enable us to have many controls over the cellular functioning and phenotype. Such
controls are often accomplished by means of genetic modifications or drug treatment,
which perturb properties of components or interactions in a biological network. As a
result, desired cellular properties or dynamical behaviors might be achieved to facilitate
the development of many applications, ranging from therapeutic strategies for diseases
(Khosla and Keasling, 2003) to industrial applications of metabolic engineering (Raab
et al., 2005) and synthetic biology (Andrianantoandro et al., 2006; Heinemann and
Panke, 2006) such as production of various biochemical substance including proteins
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(Vives et al., 2003), amino acids (Park and Lee, 2010), biofuels (Keasling and Chou,
2008), etc. For example, L-threonine is an amino acid that has been widely used in in-
dustries of cosmetics and pharmacy (Lee et al., 2007). L-threonine has been produced
from bacteria such as Escherichia coli through biosynthetic pathways. The produc-
tivity can be improved by genetically mutating genes encoding pathway components.
The goal here is to maximize the production of L-threonine, and in the meantime, to
minimize the formation of undesirable byproducts. To achieve this goal, one has to
answer the question ”which genes shall we mutate?”. Similar questions will be raised
by all applications presented above. However, it is very difficult to answer due to the
inherent complexity of biological networks. As the number of candidate perturbation
strategies will be exponential, it is impossible to test the effect of strategies one by one
to pinpoint the best strategy. Instead, one will have to resort to computational mod-
els, on which in silico perturbations effects can be cheaply simulated and examined, to
figure out the optimal solution. We term this kind of model analysis as perturbation
optimization.




where the decision variable x denotes a perturbation, the objective function f to max-
imize quantifies simulation results of the model with the corresponding perturbation,
and c is a set of constraints specifying the requirements that must be met to ensure
cells survive and have proper functioning. A perturbation can be the mutation of a set
of genes, which will result in the changes of initial conditions or kinetic parameters in
the model. For instance, in an ODE model of metabolic pathways in E. coli Lee et al.
(2007), deleting the lysA gene will induce the initial concentration of diaminopimelate
decarboxylase to be zero. Furthermore, a point mutation replacing the 290th C with
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T of the ilvA gene will decrease the activity of threonine dehydratase and result in
the changes on related kinetic parameters. It is worth noting that the E. coli model
constructed by Lee et al. (2007) consists of 979 reactions and 814 species. Due to the
combinatorial nature of the problem, such large models will induce solution spaces con-
taining a huge number of candidate perturbations. Hence the optimization procedure is
often very computationally intensive as it requires a large amount of model simulations.
To combat the combinatorial explosion of solution space, many optimization methods
have been used in recent years. A review of several standard methods employed can
be found in Banga (2008), including Linear programming (LP) (Papoutsakis, 1984),
Bilevel optimization (BLO) (Burgard et al., 2003; Chang and Sahinidis, 2005; Gad-
kar et al., 2005a), Mixed Integer nonlinear programming (MINLP) (Vital-Lopez et al.,
2006), and Dynamic optimization (DO) (Lebiedz, 2005).
Chapter 3
Preliminaries
In this chapter, we develop the notions leading to the fact that the flows (vector fields)
that arise as the solution to our systems of ODEs will be measurable functions. This
will secure the mathematical basis for our approximation. More information can be
found in (Hirsch et al., 2004; Ammann, 1990; Durrett, 2004; Feldman, 2008).
3.1 Continuity, Probability and Measure Theory
Let N denote the set of non-negative integers. Assume that X and Y are metric spaces
(Bryant, 1985). A function f : X → Y is said to be of class Ck, where k ∈ N, if
the derivatives f ′, f ′′, . . ., f (k) exist and are continuous. Thus, the class C0 consists
of all continuous functions and the class C1 consists of all continuously differentiable
functions.
A σ-algebra over a set X is a nonempty collection of subsets of X that is closed
under complementation and countable unions. The Borel σ-algebra on a topological
space X, denoted as BX , is the minimal σ-algebra containing all the open sets of X.
A probability space is a triple (Ω,F ,P) consisting of a set Ω, a σ-algebra F over
Ω, and a function P : F → [0, 1] such that:
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(i) P(Ω) = 1;
(ii) if {Aw}w∈W is a countable family of pairwise disjoint sets in F , then P(∪wAw) =∑
w P(Aw).
Let X and Y be nonempty sets and M and N be σ-algebras of subsets of X and
Y respectively. A function f : X → Y is said to be (M,N )-measurable if
E ∈ N ⇒ f−1(E) ∈M. (3.1)
The following fact is crucial for our purposes.
Proposition 3.1. (Feldman, 2008) If X and Y are metric spaces and f : X → Y is
continuous, then f is (BX ,BY )-measurable.
3.2 ODEs and Flows
Through the rest of this chapter, we assume a set of ODEs
x˙i(t) = fi(x(t),p) (3.2)
involving the variables {x1, x2, . . . , xn}. Each variable xi(t) is a real-valued function of
t with the domain of t being the set of reals. {p1, p2, . . . , pm} is the set of real-valued
parameters. We will require the ODEs to be autonomous in the sense t does not appear
explicitly in any fi. In our setting, we will often be interested in studying the dynamics
for different combinations of values for the parameters. Hence it will be convenient to
treat them also as variables. However they will be time-invariant; once their values are
fixed at t = 0, these values will not change through the passage of time. Consequently,
we will implicitly assume m additional differential equations of the form p˙j(t) = 0 with
j ranging over {1, 2, . . . ,m}. We will often let v range over Rn+, the values space of the
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variables and k range over Rm+ , the values space of the parameters and z range over
Rn+m+ , the combined values space. In vector form, our system of autonomous ODEs
may be represented as:
Z′ = F (Z). (3.3)
We shall assume that the ODEs will be modeling mass action or Michaelis-Menten
kinetics (Klipp et al., 2005). However, our method will be applicable for many other
types of reaction kinetics too.




where ri is the number of reactions associated with species xi and cj = −1 (cj = +1)
if xi is a reactant (product) of the jth reaction. Further, the quantities nij ∈ Z denote
the stoichiometric coefficients and gj are rational functions of the form gj = pαxaxb
(mass action) or gj = pαxaxb/(pβ + xa) (Michaelis-Menten) with a, b ∈ {1, 2, . . . , n}
and α, β ∈ {1, 2, . . . ,m}, describing the kinetic rates of the corresponding reactions.
Consequently, we shall assume that gi are differentiable and g
′
i are continuous on R+.
As a result, gi are C
1 (continuously differentiable) functions. This leads us to fi ∈ C1
for each i and hence F : Rn+m+ → Rn+m+ can also be assumed to be a C1 function.
Furthermore, the variables representing the concentration level of a species within a
single cell as well as the parameters capturing the reaction rates will take values from
a bounded interval. Hence the domain of F can be restricted to a bounded region D
of Rn+m+ .
Given z0 = (v0,k) where v0 specifies the initial values of the variables and k
specifies the parameters values, the system of ODEs will have a unique solution since
F ∈ C1 (Hirsch et al., 2004). We shall denote this solution by Z(t) with Z(0) = z0
and Z′(t) = F (Z(t)). We are guaranteed that Z(t) will be a C0-function (Hirsch et al.,
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2004).
It will be convenient to define the flow Φ : R+ ×D → D of Z′ = F (Z) for arbitrary
initial vectors z. It will be a C0-function given by: Φ(t, z) = Z(t) with Φ(0, z) = Z(0) =
z and ∂(Φ(t, z))/∂t = F (Φ(t, z)) for all t (Hirsch et al., 2004). Further, Φ(t, ·) will be
bijective.
Since the flow Φ is C0, i.e. continuous and D ⊆ Rn+m is a metric space we are
assured that Φ(t, ·) is (BD,BD)-measurable by Proposition 3.1. In what follows, we use
Φt to denote Φ(t, ·) and summarize the above observations via:
Proposition 3.2. Suppose Z′ = F (Z) is an autonomous system of ODEs with F in
C1 and with the domain of F being a bounded region D of Rn+m+ . Then there exists a
unique flow Φ : R+ × D → D for arbitrary initial vectors z satisfying: Φ(t, z) = Z(t)
with Φ(0, z) = Z(0) = z and ∂(Φ(t, z))/∂t = F (Φ(t, z)) for all t. Further, Φ(t, ·) will
be in C0 and hence BD-measurable. As a result, for all t ∈ R:
B ∈ BD ⇒ Φ−1t (B) = {z ∈ D | Φ(t, z) ∈ B} ∈ BD. (3.5)
3.3 Markov Chains
A Markov Chain (Norris, 1997) is a pair (S, {pij}) where S = {s1, s2, . . . , snˆ} is set
of states and pij ∈ [0, 1] are the transition probabilities with Σnˆj=1pij = 1 for every i.
Thus if the system is in state si at t then it will be in state sj at t+ 1 with probability
pij . Given an initial probability distribution Ψ
0 over S at t = 0, viewed as an 1× nˆ-row
vector, the probability distribution Ψk over S at t = k will be given by (Ψ0)T k where
T is the nˆ× nˆ transition probability matrix with Tij = pij .
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3.4 Bayesian Networks
A Bayesian network (Russell and Norvig, 2003) is a finite acyclic directed graph
BN = (V,E) which has a finite-valued random variable Xv and a conditional prob-
ability table CPTv associated with each node v. The entries in CPTv will be of
the form Pr(Xv = x|Xv1 = x1, Xv2 = x2, . . . , Xvj = xj) where {v1, v2, . . . , vj} is
the set of parents of v given by Pa(v) = {u | (u, v) ∈ E}. BN represents -often
compactly- the joint probability distribution over the random variables {Xv}v∈V given
by: Pr(Xv1 = x1, Xv2 = x2, . . . , Xvnˇ = xnˇ) =
∏nˇ
i=1 Pr(Xvi = xi|Xvi1 = xi1, Xvi2 =
xi2, . . . , Xvij = xij) with Pa(vi) = {vi1, vi2, . . . , vij}.
3.5 Dynamic Bayesian Networks
Dynamic Bayesian networks (DBNs) are Bayesian networks that model temporal
evolution of systems whose (local states) are modeled as random variables (Murphy,
2002). There are many variants of dynamic Bayesian networks. We will be dealing
with a restricted class of time-variant two-slice dynamic Bayesian networks. They will
be of the form (B0, {Bd→}dˆd=1, Pa), where B0 defines the initial probability distributions
{Pr(X0i )} of the random variables {Xi}li=1. And {Bd→} are two-slice temporal Bayesian
networks for the time points {t1, . . . , tdˆ}. The nodes of the Bayesian network Bd→
denoted V d is given by V d = {Xd−1i | 1 ≤ i ≤ l} ∪ {Xdi | 1 ≤ i ≤ l} (here we
are identifying the nodes with the random variables associated with them). The edge
relation Ed will be the subset of {Xd−1i | 1 ≤ i ≤ l} × {Xdi | 1 ≤ i ≤ l} satisfying
(Xd−1j , X
d
i ) ∈ Ed iff Xj ∈ Pa(Xi). As might be expected, Pa : X → 2X with X =
{Xi | 1 ≤ i ≤ l}. Each node Xdi will also a conditional probability table CPT di
associated with it with entries of the form Pr(Xdi = x | Xd−1i1 = xi1, . . . Xd−1ij = xij),
where Pa(Xi) = {Xi1, . . . Xij}.
Thus the way the nodes of the (d+ 1)th layer are connected to the nodes of the dth
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layer will remain invariant. However CPT d+li will be, in general, different from CPT
d
i .
An example of such a dynamic Bayesian network is shown in Figure 3.1. To avoid
clutter we have not shown the CPTs associated with each node. In our setting these
dynamic Bayesian networks will represent an associated Markov chain in a factored
form.
Pa(X1) = {X1, X3}
Pa(X2) = {X2, X1, X4}
Pa(X3) = {X3}
Pa(X4) = {X4}
Figure 1: A DBN example.
1. We start with a system of ODEs; a discretization of the value space of each variable and
rate constant into a finite set of intervals; and a discretization of the temporal domain of
interest into a finite set of time points {t0, t1, . . . , tmax}. We also assume a prior distribution
of the initial values (usually, a uniform distribution) over some of the intervals of the value
space. The flow induced by the system of ODEs, together with the prior distribution of initial
values will induce a Markov chain MCideal via the discretization. In a sense, this Markov
chain represents the dynamics of an uncountably infinite family of trajectories TRAJideal,
defined by the given set of initial values (and their prior probabilities).
2. One can not explicitly compute MCideal when the ODEs system does not admit a closed
solution. However, it can be approximated by sampling the set of initial values according to
the prior and using numerical integration to generate a representative subset TRAJapprox ⊆
TRAJideal of trajectories. Then, using the discretization and simple counting, we can con-
struct the Markov Chain MCapprox which will approximate MCideal.
3. However, MCapprox can be very large since the number of states that this Markov chain will
be, in the worst case, exponential in the number of variables. To get around this, we exploit
the pathway structure (i.e. the way the variables are coupled to each other in the system
of ODEs) to represent MCapprox compactly as a time-variant two-slice dynamic Bayesian
network. This representation of MCapprox is our final destination and will be called the
Bayesian Dynamics Model (BDM).
It is important to note that this three step procedure is just a conceptual framework; we
construct the BDM directly from the given system of ODEs instead of passing through a Markov
chain. We shall now provide more technical description the steps involved in constructing the BDM
model.
3.1. The Markov Chain MCideal
Pathways models are usually validated by experimental data available only for a few time points
with the concentrations measured at the final time point typically signifying the steady state value.
Hence we assume the dynamics is of interest only for discrete time points and that too only up to
a maximal time point. We then denote these time points as t0, t1, . . . , tmax. It is not necessary to
uniformly discretize the time domain. However, to simplify the notations of the following sections,
we fix a time step ∆t > 0 and the time points of interest is assumed to be the set {d ·∆t} with d
ranging over {0, 1, . . . , dˆ}. Thus dˆ ·∆t is the maximal time point of interest.
Next we assume that the values of the variables can be observed with only finite precision
and accordingly partition the range of each variable xi into L






i ), . . .,
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Figure 3.1: A DBN example.
Chapter 4
The Dynamic Bayesian Network
Approximation
Here we present our technique for approximating the pathway dynamics defined by a
system of ODEs as a dynamic Bayesian network (DBN).
At the first step we show how the discretization of the value space and time domain
leads to the derivation of a Markov chain from the ODEs dynamics. We then show
how this Markov chain can be further approximated as a dynamic Bayesian network
by introducing independence assumptions obtained from the network structure.
4.1 Overview
Conceptually, our approximation technique consists of two major steps. First we dis-
cretize the value spaces of the variables and parameters into a finite set of intervals.
We also discretize the time domain of interest into a finite number of time points. In
addition, we assume a prior distribution of initial values over the intervals. As a result,
the flow defined by our system of ODEs will induce a Markov chain MCideal.
In the second step we further approximateMCideal as a dynamic Bayesian network
49
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(DBN). This second step is motivated by a number of considerations. To start with,
MCideal can not be computed explicitly since the ODEs systems of interest will not
admit closed form solutions. Secondly, if we approximateMCideal directly as a Markov
chain, say MCapprox, then the resulting Markov chain’s size will be exponential in the
number of variables involved in the ODEs system. To get around this we introduce
independence assumptions based on the way the variables are coupled to each other
in the biochemical reactions network. We then approximate MCideal as a dynamic
Bayesian network, which in this context, may be viewed as a factored Markov chain.
We compute the conditional probability tables of the DBN by sampling the initial
states according to the prior sufficiently many times and generating a trajectory for
each of the sampled initial states. Then by a simple process of counting tied to the
discretized value space and time domain, we obtain the dynamic Bayesian network.
This two step procedure is however just a conceptual framework. We shall construct
the DBN approximation directly from the given system of ODEs instead of passing
through a Markov chain. We now proceed with a more technical description the steps
involved in constructing the DBN approximation. In doing so, we shall assume that we
are given the system of ODEs x˙i(t) = fi(x(t),p) with n variables and m rate parameters
specified in the previous chapter with the associated notations and assumptions.
4.2 The Markov Chain MCideal
Biological pathway models are usually validated by experimental data available only
for a few time points with the concentrations measured at the final time point typically
signifying the steady state value. Hence we assume the dynamics is of interest only for
discrete time points and that too only up to a maximal time point. We denote these
time points as {t0, t1, . . . , tmax}. It is not necessary to uniformly discretize the time
domain. However, to simplify the notations of the following sections, we fix a time step
∆t > 0 and the time points of interest is assumed to be the set {d ·∆t} with d ranging
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over {0, 1, . . . , dˆ}. Thus dˆ ·∆t is the maximal time point of interest.
Next we assume that the values of the variables can be observed with only finite pre-
cision and accordingly partition the range of each variable xi into L









i ]. We denote this set of intervals as Ii. We also similarly dis-
cretize the range of each parameter pj into a set of intervals denoted as In+j . The set
I = {Ii}1≤i≤n ∪ {In+j}1≤j≤m is called the discretization. Again, we wish to empha-
size that the value space can be discretized non-uniformly and our constructions will
go through.
As pointed out earlier, the initial values as well as the rate constants (even when they
are known) will be given not as point values but as distributions (usually uniform) over
the intervals defined by the discretization. We correspondingly assume we are given a
prior distribution in the form of a probability density function Υ0 capturing the initial
values.
For example, suppose we are given that the initial values are uniformly distributed
within a hypercube Iˆ1 × Iˆ2 × . . . × Iˆn+m, where Iˆi ∈ Ii for each i. Let Iˆi = [li, ui)





wˆ1·wˆ2·...·wˆn+m if z ∈ Iˆ1 × Iˆ2 × . . .× Iˆn+m,
0 otherwise.
(4.1)
The associated probability space we have in mind is (D,BD,P0) where D is the
domain of the ODEs (see Section 3.2), BD is the Borel σ-algebra over D; the minimal
σ-algebra containing the open sets of D under the usual topology. P0 is the probability




Υ0(z)dz, for every B ∈ BD. (4.2)
Further, TRAJideal = {Φt(z)}t≥0 with z ranging over Iˆ1 × Iˆ2 × . . . × Iˆn+m is the
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family of trajectories starting from all the possible points in this hypercube. As before,
Φ is the flow induced by the system ODEs.
Φ is measurable by Proposition 3.1. Hence we can define the probability distribution
Pt over BD for every t as:
Pt(B) = P0(Φ−1t (B)), for every B ∈ BD. (4.3)
Let v be a real number in the range of xi. We define [v] as the interval in which v
falls. In other words, [v] = I iff v ∈ I. Similarly, [k] = J if k ∈ J for a parameter value
k of pj with J ∈ In+j .
Lifting this notation to the vector setting, if z = (v1, v2, . . . , vn, k1, k2, . . . , km) ∈
Rn+m+ , we define [z] = ([v1], [v2], . . . , [vn], [k1], . . . , [km]) and refer to it as a discrete
state.
Definition 4.1. An MC-state is a pair (s, d), where s is a discrete state and d ∈
{0, 1, . . . , dˆ}.
We next define Pr((s, d)) = Pd·∆t({z | z ∈ I1 × I2 × . . . × In+m}), where s =
(I1, I2, . . . , In+m). We term the MC-state M to be feasible iff Pr(M) > 0.
Definition 4.2. The transition relation denoted as →, between MC-states is defined
via: M = (s, d)→M ′ = (s′, d′) iff d′ = d+1 and both M and M ′ are feasible and there
exist z0, z, and z
′ such that Φ(d ·∆t, z0) = z and Φ((d+1) ·∆t, z0) = z′. Furthermore,
[z] = s and [z′] = s′.
Let E, F denote, respectively, the event that the system is in the discrete state
s at time d · ∆t and in the discrete state s′ at time (d + 1) · ∆t for two feasible
MC-states (s, d · ∆t) and (s′, (d + 1) · ∆t). Let EF = E ∩ F denote joint event
{z0 | Φ(d ·∆t, z0) ∈ s,Φ((d+ 1) ·∆t, z0) ∈ s′}. Consequently, we define the transition
probability Pr((s, d) → (s′, d′)) = Pr(F |E) = Pr(EF )/Pr(E). Since Pr(E) > 0 this
transition probability is well-defined.
CHAPTER 4. THE DYNAMIC BAYESIAN NETWORK APPROXIMATION 53
Definition 4.3. Let M = {M1,M2, . . . ,Mnˆ} be the set of M-states. We can now
define the Markov chain MCideal = (M, {pij}) with transition probabilities pij =
Pr(Mi →Mj) as above.
Example A typical biochemical equation depicting an enzyme catalyzed reaction can






k3−→ E + P (4.4)
As the basic component of signal transduction pathways (Stryer, 1988), it accounts
for one step in the transduction of a signaling cascade. In this reaction, the enzyme
E binds reversibly to the substrate S, before converting it into the product P and
releasing it. The parameters k1, k2 and k3 are the rate constants that govern the speed
of these reactions. The corresponding ODE model will be:
dS
dt
= −k1 · S · E + k2 · ES
dE
dt
= −k1 · S · E + (k2 + k3) · ES
dES
dt
= k1 · S · E − (k2 + k3) · ES
dP
dt
= k3 · ES
Assuming that the range of each variable or parameter is: S ∈ [0, 15], E ∈ [0, 10],
ES ∈ [0, 10], P ∈ [0, 15], k1 ∈ [0, 1], k2 ∈ [0, 1], k3 ∈ [0, 1] (for simplicity, we ignore all
units in this example), we partition each range into 5 equal-sized intervals and form
the discretization I = {IS , IE , IES , IP , Ik1 , Ik2 , Ik3}, where IS = IP = {[0, 3), [3, 6),
[6, 9), [9, 12), [12, 15]}, IE = IES = {[0, 2), [2, 4), [4, 6), [6, 8), [8, 10]} and Ik1 = Ik2 =
Ik3 = {[0, 0.2), [0.2, 0.4), [0.4, 0.6), [0.6, 0.8), [0.8, 1]}. We fix the time step ∆t to be
0.1 and fix the number of time points to be 100. We have adopted equal-sized intervals
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and fixed time steps only for convenience.
Suppose we are given a prior distribution that the initial values z0 = (S, E, ES, P ,
k1, k2, k3) are uniformly distributed within a hypercube C = [12, 15]× [8, 10]× [0, 2)×
[0, 3) × [0.2, 0.4) × [0.4, 0.6) × [0.2, 0.4). We then have the prior probability density






36 if z ∈ C,
0 otherwise.
Thus, M0 = (s0 = ([12, 15], [8, 10], [0, 2), [0, 3), [0.2, 0.4), [0.4, 0.6), [0.2, 0.4)), 0) will be
the initial MC-state of the induced Markov chain MCideal. Clearly Pr(M0) = 1 since
Pr(M0) = P
0({z | z ∈ C}) =
∫
{z|z∈C}
Υ0(z)dz = 1. (4.5)
The ODEs system will typically not admit a closed form solution. Hence Φ can not
be derived explicitly and as a consequence, MCideal can not be explicitly computed
either. Thus, one can only compute approximations of MCideal. For instance, one
could sample z (the initial state) many times according to the prior distribution P0
and for each sampled initial z, determine through numerical integration the M-states
[Φ(d · ∆t, z)], with d ranging over {0, 1, . . . , dˆ} as well as the transitions along this
trajectory. Then through a simple counting process involving the generated trajectories,
a Markov chain can be computed as an approximation ofMCideal. However, the number
of states of such approximated Markov chain will be exponential in n. As a result, for
many biological pathways, it will be simply too large. Instead, we shall construct a
time-variant two-slice DBN to compactly represent and approximate MCideal.
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4.3 The DBN Representation
The key observation is that the structure of the system of ODEs can be exploited to
factorizeMCideal into a time-variant 2-slice DBN. This DBN will have (n+m)×(dˆ+1)
nodes. The node v will have associated with it a random variable Xdi . This random
variable will take as values the intervals in Ii; the intervals into which the value space
of xi (in case i ≤ n) or the parameter pi−n (in case i > n) has been discretized. The
superscript d will stand for the fact the probability distribution associated with Xdi
describes the probability of the value of the variable xi (or the parameter pi−n) falling
into various intervals in Ii at time d ·∆t (since the parameter pi−n is a constant, it can
be associated with dpi−ndt = 0 ). In what follows, for convenience, we will use the same
name to denote a node and the random variable associated with it. From the context
it should be clear which role is intended. We now proceed with the construction of the
DBN (B0, {Bd→}dˆd=1, Pa).
We assume that the prior distribution of initial values of the variables and parame-
ters are independent of each other. This is often a reasonable assumption. Even when
the assumption is violated it is certainly reasonable to assume that marginal prior prob-
abilities of each variable and parameter can be computed and thus B0 = {Pr(X0i )}n+mi=1
can be computed. Next, the parent relation Pa is defined as follows. In doing so, it
will be convenient to identify the variable xi with Xi and the parameter pj with Xn+j .
Suppose z, z′ ∈ {x1, x2, . . . , xn, p1, p2, . . . , pm}. Then z′ ∈ Pa(z) iff z′ = z or z is a
variable and z′ appears in the right-hand side of the equation for dz/dt in the system
of ODEs.
Thus the structure of the ODEs and more precisely, the structure of the biochemical
network induces the underlying graph of the DBN.
V d, the set of nodes of the Bayesian network Bd→ = (V d, Ed) will be: V d = {Xd−1i |
1 ≤ i ≤ n + m} ∪ {Xdi | 1 ≤ i ≤ n + m}. The edge relation Ed is defined in the
obvious way now using the function Pa. To spell it out, it will be the subset of
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Figure 4.1: A slice of the DBN approximation of the enzyme-kinetic system.
{Xd−1i | 1 ≤ i ≤ n + m} × {Xdi | 1 ≤ i ≤ n + m} satisfying (Xd−1j , Xdi ) ∈ Ed iff
Xj ∈ Pa(Xi).
Finally, suppose Pa(xi) = {z1, . . . , zl}. Then conditional probability table (CPT)
associated with the node Xdi will have entries of the form Pr(X
d
i = I | zd−11 =
I1, . . . , zd−1l = I
l) = h with I ranging over Ii and Ij ranging over Ij for 1 ≤ j ≤ l and
h ranging over [0, 1]. This entry captures probability of the value of the variable xi
(assuming i ≤ n) falling in the interval I at time d ·∆t given that at time (d− 1) ·∆t,
the value of the variable (parameter) zj was in the interval I
j for 1 ≤ j ≤ l. It is in this
sense the dynamics defined by MCideal is captured in a factored form by the DBN.
Example (continued) Figure 4.1 shows two adjacent slices in the DBN approxi-
mation of the enzyme-kinetic system. The structure of this DBN is derived from the
ODEs presented in section 4.2. For instance, the parent nodes of P d+1 are P d, ESd
and kd3 since P
d, P d+1 refer to the same variable P while ES, k3 appear in the ex-
pression for dP/dt. As mentioned earlier, the parameters are assumed to retain their
values during a run and hence we denote kdi as simply ki and there will be no CPTs
associated with these nodes. On the other hand, the CPT associated with the node
P d+1 will have entries of the form Pr(P d+1 = I | P d = I ′, ESd = I ′′, k3 = I ′′′) = h,
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where I, I ′ ∈ IP , I ′′ ∈ IES , I ′′′ ∈ Ik3 and h ∈ [0, 1]. As illustrated in this example, the
connectivity between the nodes in successive slices will remain invariant. However, due
to the fact that the CPTs associated with the nodes capture the transition probabilities
at different time points, they will be time variant.
MCideal will have, in the worst case, O((dˆ+ 1)Kn) states and O(dˆK2n) transitions,
where K is the maximum of |Ii| with 1 ≤ i ≤ n + m. In contrast, the number of
nodes in the DBN representation is O(dˆ(n+m)) and the conditional probability table
associated each node will have at most O(KR+1) entries, where R is the maximal
number of parents a node can have. Usually, the reactants in pathway models will be
sparsely coupled to each other and hence R will be much smaller than n. For instance,
in the first case study to be presented in the next chapter, n = 32 and R = 5.
Since our ODE system will not admit a closed form solution, the conditional prob-
abilities of the DBN can not be directly derived explicitly. To fill up the entries of the
CPTs associated with the nodes of DBN, we shall approximately compute conditional
probabilities as follows.
We sample z (the initial state) a sufficiently large number of times, say N , according
to the prior distribution P0 (we say more about N below). Since we assume that the
initial values are independent of each other, the values of a variable/parameter can
be sampled according to its marginal prior distribution. For instance, in our running
example, we can randomly choose a value from [12, 15] for S, a value from [8, 10] for E,
a value from [0, 2) for ES, a value from [0, 3) for ES, a value from [0, 1] for k1, a value
from [0, 1] for k2, a value from [0, 1] for k3, and then form a vector of initial values.
After picking N sample initial value vectors, we perform numerical integration to
generate N trajectories and discretize those trajectories by the predefined intervals and
compute the conditional probabilities for each node by simple counting. For example,
suppose 132 trajectories hit (P 0 = [0, 3), ES0 = [0, 2), k3 = [0.2, 0.4)) at time 0 and 12
of them in turn hit (P 1 = [3, 6)) at time 0.1, then Pr(P 1 = [3, 6) | P 0 = [0, 3), ES0 =
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[0, 2), k3 = [0.2, 0.4)) = 12/132 = 0.091.
As a result, we can obtain a DBN approximating the idealized DBN induced by
introducing the conditional independences to MCideal. It is not difficult to show that
a canonical Markov chain can be recovered from the DBN (Nunez, 1989). We note
that this Markov chain is an approximation of MCideal. In next section, we discuss
the error between them due to the following: (i) factorizing MCideal into the idealized
DBN is based on assumed conditional independences, (ii) the N trajectories used for the
construction of the approximated DBN are generated through numerical integration,
and (iii) the sample size N is finite.
4.3.1 Error Analysis
The error induced by the numerical integration will depend on the method adopted.
For example, the step’s errors of Euler’s method and fourth-order Runge-Kutta method
described in Section 2.3.1 are O(h2) and O(h5) respectively, where h is the step size.
In general, the error induced by the pth-order numerical integration method is O(hp+1)
(Press et al., 1992) and it will tend to 0 as h tends to 0 or p tends to ∞.
Further, numerical integration methods compute zi(t+δ) using zi(t) and the values,
at time t, of other variables/parameters that appear in the right-hand side of the
equation for dzi/dt (see the formulas of Euler’s method and RK4 in Section 2.3.1).
In other words, the value of zi(t + δ) only depends on the values of zj(t) where zj ∈
Pa(z). Hence the independence assumption is consistent with the numerical integration
methods. There will be no additional error induced by the independence assumption
when ∆t in the DBN equals to δ used for generating the trajectories.
Since N is finite, there will be an error between the conditional probabilities com-
puted using the N trajectories and the ones induced by MCideal. By the central limit
theorem (Durrett, 2004), this error can be probabilistically bounded. For each entry
of the DBN, let rˆ represent the conditional probability computed via sampling and r
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be the actual one induced by the MCideal, we have:
Proposition 4.4. Suppose the number of samples is N . Then  will be the error with














Proof. Let X be a random variable such that X = 1 (X = 0 resp.) denote the event
that a sample trajectory passes (not passes resp.) a discrete state s at time d·∆t. Hence
X will have a Bernoulli distribution with parameter pij with µ = r and σ
2 = r(1− r).























Therefore, given an error bound  and a confidence level c, we can compute N , the
number of samples required to get an error less than or equal to  with likelihood c. For
instance, let  = 0.01 and c = 0.95. To estimate Pr(P 1 = [3, 6) | P 0 = [0, 3), ES0 =
[0, 2), k3 = [0.2, 0.4)), we need d(
√
0.091(1− 0.091) · φ−1((0.95 + 1/2)/0.01)2e = 3178
samples. Further, this error will tend to 0 with probability 1 as N tends to ∞.
The above error analysis is preliminary. It mainly aims to show that the error
between our approximation and MCideal induced by the pathway dynamics can tend
to 0 under certain condition. In practice, to construct the DBN, one will need to make
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a chose of N . However, it is difficult to determine N with guaranteed error bounds
since MCideal is not computable. Hence one must make a pragmatic choice of N . In




Since we have n variables andm parameters, theN sampled initial values vectors should
be picked from a (n + m)-dimensional space. According to the prior distribution, the
value of each variable or known parameter often lies in one interval. For instance, the
value of species E in our running example lies in [8, 10]. Thus, for existing models
or for those for which the parameter estimation has already been carried out, we can
randomly pick a value for each variable/parameter according to their marginal prior
and then form a vector of initial values. We term this type of sampling as direct
sampling. This method does not ensure any coverage. One can determine N based on
the computational time one would like to spend on the DBN construction.
Global sampling
However, the value of an unknown parameter will range over all its intervals. For
instance, in our running example, the value of each unknown parameter should be
sampled from 5 intervals. Thus if we have u unknown parameters whose value spaces
have been discretized to K intervals each, one will require a sample size of N = J ·Ku
to ensure J samples for each possible combinations of interval values of the unknown
parameters. We term this as global sampling. Thus the number of samples this method
would require will be exponential in the number of unknown parameters. This will often
be an unacceptably large number.
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Local sampling
At the other end of the spectrum, we can pick J samples for each possible interval
of variables or parameters. The idea is to randomly choose a point within the target
interval I of, say, the variable xi and then arbitrarily extend this point value to an (n+
m)-dimensional vector over the allowed intervals of the other variables and parameters.
We term this as local sampling and it will require a sample size of N = (n+m) · J ·K
with coverage of J per interval. Hence local sampling will require a much smaller
sample size. However, it can not guarantee adequate coverage for combinations of
interval values of the parameters.
To bring this out through an artificial but simple case, suppose x takes values in
the interval I1 and I2 while y takes values in the intervals I3 and I4. To get a local
coverage of 100 samples per interval, we may pick 100 points from I1 and extend it
by combining it with a random value for y (which will fall in I3 or I4). Let S1 be the
set of such samples. Similarly let S2 be the set of 100 samples obtained by picking
100 points from I2 and extending each of them randomly to a value for y. Finally, let
S3 (S4) be the 100 samples obtained by picking 100 values from I3 (I4) and extending
each of them randomly to a value for x. In this way, with 400 samples we will be able
to guarantee a minimum of 100 hits for each of the intervals {I1, I2, I3, I4}. However
suppose the y-values of all the samples in S1 (S2) fall in S3 (S4) and the x-values of all
the samples in S3(S4) fall in S1(S2). Then none of the 400 samples will fall in I1 × I4
(I2 × I3) and hence we will get 0-coverage for the combination of this pair of intervals!
To ensure that we are exploring the ODEs dynamics adequately, we need to ensure
that all the possible combinations of interval values of unknown parameters govern-
ing any single equation are being sampled an adequate number of times. Otherwise,
the probabilistic inference we need to to perform on the DBN approximation during
parameter estimation and sensitivity analysis will have poor quality.
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Equation sampling
Hence to get good coverage in the presence of many unknown parameters, one will have
to resort to more sophisticated methods. Here we propose a method called equation
sampling by which numerical simulations can be carried out in the presence of unknown
parameters while ensuring that the local dynamics defined by the individual equations
are being explored adequately. To bring out the main idea, suppose the equation for
the variable xi involves the unknown parameters k1 and k2 and the values of k1 (k2)
have been divided into three intervals I1 (I
′
1) , I2 (I
′
2) and I3 (I
′
3). Then for a specific
combination of intervals, say I2 and I
′
3 we pick 100 samples such the k1 value lies in I2
and the k2 value lies in I
′
3 for each of the samples. In this way we can pick 900 samples
which ensure that there are at least 100 samples for each combination of interval values
for k1 and k2. In general, we will be able provide a coverage of J samples for each
possible combination of interval values of the unknown parameters in the equation
for each variable with the help of N = n · J · KR samples, where R is the maximal
number of unknown parameters appearing in an equation. Since the positive terms
(negative terms) in the differential equation of a species describe the rates of reactions
that producing (consuming) this species, equation sampling will provide of a coverage
of all possible local conditions that determines the dynamics of a single species. Thus,
with this type of sampling, the quality of model analysis tasks can be ensured with an
acceptable sample size.
4.3.3 Optimizations
Various optimizations can be developed to reduce the practical complexity of the DBN
construction. Specifically, the sampling process followed by the generation of a tra-
jectory can be easily parallelized and executed on a computing cluster. In addition,
the CPTs can be stored using a sparse representation. Yet another optimization is
to split up a “fat” node with a large number of parents into nodes with smaller fan-
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Figure 4.2: Node splitting.
in degrees and thus reduce R. As shown in Figure 4.2, the reduction can be based
on the form of the differential equation associated with the variable. Given that
dES/dt = k1 · S · E − (k2 + k3) · ES, we introduce two internal nodes X and Y ,
where X corresponds to the positive term of dES/dt, namely, k1 · S · E and Y corre-
sponds to the negative term (k2 + k3) ·ES. As a result, R can be reduced from 6 to 3.
We note however, at present we consider this optimization only to reduce the sizes of
the CPTs and not to reduce the number of samples when using the equation sampling
method.
4.4 Discussion
In this chapter, we have described our probabilistic approximation scheme for pathway
dynamics specified as a system of ODEs. For sure, the construction of the DBN ap-
proximation will involve a significant computational effort but it is a one time cost and
significant optimizations can be deployed. Moreover, once the DBN approximation has
been constructed, many of the analysis tasks can be performed very efficiently and the
CHAPTER 4. THE DYNAMIC BAYESIAN NETWORK APPROXIMATION 64
one time cost of constructing the DBN approximation can be easily amortized. The
experimental results presented in Chapter 6 will support this claim.
Chapter 5
Analysis Methods
In this chapter we present some of the analysis techniques we have developed for
the DBN representation. These techniques are founded on a basic Bayesian infer-
ence method realized via the FF (Factored Frontier) algorithm (Murphy and Weiss,
2001). Specifically we develop parameter estimation and sensitivity analysis methods
for the DBN approximation. Our goal here is not to develop new algorithms to solve
these problems. Rather, we wish to demonstrate how standard techniques for tackling
these problems can be adapted to DBN approximation framework.
5.1 Probabilistic Inference
Given a Bayesian network, some observed evidence and some knowledge about the
distribution of values of a set of variables, Bayesian inference aims to compute posterior
distribution for a set of query variables. In our setting, the observed evidence will
consist of known initial conditions and parameters as well as experimental data. Query
variables will typically be selected random variables in the DBN approximation.
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Exact inference
As the state space of our DBN is discrete, exact inference is always theoretically possible
(Murphy, 2002). In this case, there will be no error induced by performing inference.
However, the exact inference often be computationally prohibitive. For instance, the
time and space complexity of the frontier algorithm (Zweig, 1996) -a standard exact
inference algorithm- is O(dˆ(n+m)Kn+m+2) , where as before, dˆ is the number of time
slices of the DBN, n is the number of variables, m is the number of parameters and K
is the maximal number of intervals associated with a variable or rate constant’s value
domain. Hence for large pathway models, we must resort to approximate inference
methods.
Boyen-Koller algorithm
The Boyen-Koller (BK) algorithm (Boyen and Koller, 1998, 1999) is a standard algo-
rithm for approximate inference on DBN. It approximates the joint distribution over
the variables in one time slice (a belief state) as a product of marginals over clusters




3) ≈ Pr(xd1, xd2)Pr(xd3). When we do infer-
ence using BK in our setting, starting with the approximated belief state of current
time slice Pr(xd1, x
d
2, . . . , x
d
n+m), we perform one step of exact Bayesian updating to get
Pr(xd+11 , x
d+1
2 , . . . , x
d+1
n+m), which will be then projected as a product of marginals over
clusters of variables.
A great advantage of the BK algorithm is that the error induced can be shown to
be bounded over time. The detailed proof can be found in Boyen and Koller (1998).
Intuitively, even though projection introduces an error at every time step, the stochastic
nature of the transitions and the informative nature of the observations, will reduce
the error sufficiently to stop it building up.
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Factored frontier algorithm
Unfortunately, for large pathway models, the one-step exact updating of BK algorithm
can still be intractable. Therefore, we adopt a more aggressive form of approximation
than BK, namely, the factored frontier (FF) algorithm (Murphy and Weiss, 2001).
The FF algorithm approximates, at each time point, joint distributions as products








i ). Hence the








Here Pr(u|D) are the marginal distributions over the parents, D is the evidence regard-
ing initial conditions and experimental observations, and Pa(xi) denotes the parents of
xi. The implementation of FF is straightforward. By storing Pr(x
d
i |Pa(xdi )) in the con-
ditional probability tables and propagating Pr(u|D) to the next time point, we can use
(5.1) to compute Pr(xdi |D). The time complexity of this algorithm is O(dˆ(n+m)KR+1),
where as before, K is the maximal number of intervals associated with a variable or
rate constant’s value domain and R is the maximal number of parents a node can have.
Except for the one-step exact updating, FF is very close to the fully factorized
BK that use one cluster per variable. Currently, there are no error analysis for FF.
However, experimentally comparisons results of exact, BK and FF show that the error
induced by FF is acceptable and close to the fully factorized BK (see Figure 5.1). Here




|Pr(xdi = I)− P̂ r(xdi = I)| (5.2)
where P̂ r(·) is the exact posterior and Pr(·) is the approximate posterior. The results
shown in Figure 5.1 indicate that the error induced by FF is close to fully factorized
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FF 
BK 
Figure 5.1: Comparison of exact, fully factorized BK and FF inference results of the
enzyme-kinetic system.
BK.
Using the FF algorithm, and with some additional computations, many queries can
be answered. For instance, given the initial conditions, a single run of FF algorithm
will infer the marginal distributions of each variable at every time point. These prob-
ability distributions can then be used to validate the model by comparing them with
experimental data. Flow cytometry data may provide direct information about the
probability distributions of species concentration in a cell population. For such data,
we may discretize it into distributions over intervals and supply it to the FF algorithm.
On the other hand, western blot data, which is more common, will provide the aver-
ages of species concentration in a cell population. Suppose we have the data for xi
at time d ·∆t, denoted as Dd·∆txi . Note the marginal distribution of xdi inferred by FF
algorithm is over discrete values Ii. To compute the real-valued “mean” of xdi that can
be compared with Dd·∆txi , we identify each interval I = [l, u) in I with its mid-point
(l+ u)/2. Then the expected value E(xdi ) can be computed and compared with D
d·∆t
xi .
The rationale of this approach is: (1) the western blot data Dd·∆txi can be assumed to
be the observations for the mean computed from the marginal probabilities induced by
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MCideal, denoted as Eˆ(xd·∆ti ); and (2) the E(xdi ) we use to compare with the data is
an approximation of Eˆ(xd·∆ti ) with bounded error. Here we estimate the error between
Eˆ(xd·∆ti ) and E(x
d
i ) and show it is bounded as follows:
Proposition 5.1. For any xi at each time point d ·∆t, we have





Proof. As discussed in Section 3.2, Φt is a bijective and continuous function. Further,
it can be proved that Φt is also differentiable (Hirsch et al., 2004). Given the prior
probability density function Υ0 we can define the probability density function Υt for
every t as:
Υt(z) := Υ0(Φ−1t (z))
∣∣∣det(JΦ−1t (z))∣∣∣ (5.4)
where JΦ−1t
denotes the Jacobian of the inverse of Φ. We then define a probability





Υt(z1, z2, . . . , zi−1, z, zi+1 . . . , zn+m)dz1dz2 . . . dzi−1dzi+1 . . . dzn+m
(5.5)
Similarly, we define a probability mass function mxi for each variable xi at time point



















gd·∆txi (z)dz, where s = [l, u) ∈ Ii. (5.7)
Let Ii = {I1 = [v0, v1), I2 = [v1, v2), . . . , IL = [vL−1, vL]}, we set ri = (vi − vi−1)/2
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z · gd·∆txi (z)dz +
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z · gd·∆txi (z)dz + . . .+
∫ vL
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v1 · gd·∆txi (z)dz +
∫ v2
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v2 · gd·∆txi (z)dz + . . .+
∫ vL
vL−1













= v1mdxi(I1) + v









Thus, |E(xdi )− Eˆ(xi(d ·∆t))| ≤
∑
Ii
ri ·mdxi(Ii) ≤ rmax.
5.2 Parameter Estimation
Lack of knowledge about the parameters and hence the need to perform parameter
estimation using limited data is a major bottleneck to pathway modeling. As reviewed
in Section 2.4, current approaches to parameter estimation formulate it as a non-linear
optimization problem (Banga, 2008). A typical procedure will involve searching in a
high dimensional solution space, in which each point represents a vector of parameter
values. Whether a point is good or not is measured by an objective function, which
will capture the difference between experimental data and prediction generated by
simulations using the corresponding parameters.
For a large pathway model, one often needs to evaluate a very large number of
solution points involving a numerical integration for each evaluation. This makes the
process computationally intensive. The DBN representation allows us search for good
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parameter values using a two-stage method. Due to the discretized nature of the DBN
approximation, the solution space is transformed into a rectilinear grid tessellated by
hyperrectangles that we call blocks. An important observation is that kinetic param-
eters are often robust (Gutenkunst et al., 2007). In other words, the points around a
good solution in the search space will also have relatively small objective values. Note
that searching in this discrete space with finite number of blocks is much simpler than
in the original continuous solution space. Thus, instead of searching point by point
in the solution space, we can first search for a few promising blocks and then take a
closer look within these small blocks. Guided by this intuition, the general scheme of
our “grid search” algorithm consists of two stages:
(1) identify good blocks,
(2) do local search within candidate blocks.
For executing Stage (1), we can apply any standard search algorithms over the
discretized search space. As this space is much smaller than the original one, simple
direct search algorithm such as Hooke & Jeeves’s search (Hooke and Jeeves, 1961)
can be adopted and the overall search process will only require a small number of
evaluations of the objective function.
A block dictates a combination of intervals of parameter values. In order to evaluate
the goodness of a block, we execute FF algorithm once by supplying the chosen parame-
ter values -in terms of intervals- as evidence. Then the objective value can be computed
by comparing the expected value of marginal distributions with the experimental data
as described in the previous subsection.
Stage (1) will return a maximum likelihood estimate of a combination of intervals
of parameter values. Through probabilistic inference techniques, it can be used to
carry out model analysis for fixed distribution of initial concentrations. Hence, in
principle, given the noisy and limited experimental data and the high dimensionality
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of the system, one could stop with Stage (1) and try to work an interval of values for
each parameter rather than a point value.
We note that Stage (2) is necessary only when we want to estimated the real values
of parameters and use the ODE model too for some analysis and simulations that
requires perturbing the initial concentrations and a finer granularity of parameters.
For instance, in the case studies presented in Chapter 6: in the first and the second
case study, we skip Stage (2), whereas in the third case study, we execute Stage (2)
and further estimate the real values for unknown parameters for conducting in silico
experiments such as varying initial concentrations.
For executing Stage (2), we treat the resulting combination of intervals of parameter
values from Stage (1) as the (drastically reduced) search space. For an m-dimensional
search space with K discretized intervals for each dimension, Stage (1) can reduce the
search space by a factor of 1/Km. For most parameter estimation methods, reducing
the solution space increases the chance of randomly picking good starting points which
in turn will lead to faster convergence. Hence the reduction of solution space we
achieved using the DBN approximation contributes in this way too in improving the
performance of the parameter estimation procedure.
Note that during the construction of the DBN approximation, if we do not have
any knowledge about the prior distributions of unknown parameters, we can assume
they are uniformly distributed within their ranges. Then after filling up all the entries
of the CPTs of the DBN, the FF algorithm will be able to evaluate the goodness of
any block in the discretized search space.
Example (Continued from the enzyme catalysis example presented in Chapter 4)
Assume that only k1 and k2 are unknown parameters and that k3 ∈ [0.2, 0.4). Assume
further that we have experimental data for S and P at time points {1, 2, 5, 10}. We
then construct a DBN approximation according to a prior distribution that the initial
CHAPTER 5. ANALYSIS METHODS 73
values z0 = (S,E,ES, P, k1, k2, k3) are uniformly distributed within the hypercube
[12, 15] × [8, 10] × [0, 2) × [0, 3) × [0, 1] × [0, 1] × [0.2, 0.4). Since |Ik1 | = |Ik2 | = 5, the
solution space [0, 1]×[0, 1] is discretized into 25 blocks. In phase(1), we try to search for
good blocks among the 25 blocks. Suppose we conduct a Hooke & Jeeves’s search and
evaluate blocks one by one. For instance, to evaluate block ([0.4, 0.6), [0.2, 0.4)), we set
Pr(k1 = [0.4, 0.6) = 1 and Pr(k2 = [0.2, 0, 4) = 1 (the distributions of S
0, E0, ES0, P 0,
and k3 are the same as the prior distribution for constructing the DBN approximation)
and execute FF algorithm. If the inferred distribution of S10 is {Pr(S10 = [12, 15]) =
0.6, P r(S10 = [9, 12)) = 0.4}, we have E(S10) = (15−12)/2·0.6+(12−9)/2·0.4 = 12.3.
Then we can compute the weighted square root error between E(S10) and the available
data. After searching suppose we find that ([0.2, 0.4), [0.4, 0.6)) is the best block (i.e.
it has the minimal objective value), we then can either execute phase(2) by searching
within the solution space [0.2, 0.4) × [0.4, 0.6) or just return {k1 ∼ U(0.2, 0.4), k2 ∼
U(0.4, 0.6)} as a probabilistic estimate (U stand for uniform distribution).
5.3 Global Sensitivity Analysis
As discussed in Section 2.5.1, sensitivity analysis has been used to identify the critical
parameters in signal transduction (van Riel, 2006). To overcome the limitations of tra-
ditional local sensitivity analysis methods, global methods have been proposed recently
such as multi-parametric sensitivity analysis (MPSA) (Cho et al., 2003). The MPSA
procedure consists of:
(1) draw samples from parameter space and for each combination of parameters,
compute the weighted sum of squared error between experimental data and pre-
dictions generated by selected parameters;
(2) classify the sampled parameter sets into two classes (good and bad) using a
threshold error value;
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(3) plot the cumulative frequency of the parameter values associated with the two
classes;
(4) evaluate the sensitivities as the Kolmogorov-Smirnov statistic (Sheskin, 2004) of
cumulative frequency curves.
Signaling pathway models often contain a large number of parameters. Hence it is
necessary to sample a representative set from all possible combinations of parameter
values. To improve this process, (Zi et al., 2005) adopts Latin Hypercube Sampling
(LHS) since it requires fewer samples while guaranteeing that individual parameter
ranges are evenly covered. Briefly, the range of each parameter is divided into K
equal-sized intervals. Then for each parameter, one randomly sample K values, one
from each interval of the parameter. Then to generate combinations of parameter values
which is samples for MPSA, values are chosen in a random order from the K values
for each parameter. This method helps to computationally manage the large number
of parameters being varied simultaneously, while ensuring maximal sampling through
each parameter dimension (McKay et al., 2000). In our DBN setting, MPSA can be
performed in a similar manner using LHS since the parameter space is discretized into
blocks. In addition, the number of samples used to reach convergence is reduced since
we can quickly evaluate the goodness of the whole block using the FF algorithm instead
of having to draw samples from a block.
Chapter 6
Case Studies
The algorithms presented in previous chapters for constructing and analyzing DBN
approximations have been implemented in our software tool called PAthway Dynamics
Approximator (PADA). PADA is open-source and is freely available at our website1.
It is a Java program that supports the import of ODE-based pathway models in SBML
format. It can generate parallelized code, to be executed on computer clusters, for the
construction process of DBN approximations, as well as sequential code, to be executed
on a single CPU, for carrying out probabilistic inference, parameter estimation and
global sensitivity analysis.
In this chapter, we present three case studies which demonstrate the applicability of
our probabilistic approximation technique. The first case study (Section 6.1) involves
a signaling network built by Brown et al. (2004), which aims to study the influence
of the nerve growth factor (NGF) and the mitogenic epidermal growth factor (EGF)
in rat pheochromocytoma (PC12) cells. The second case study (Section 6.2) deals
with a signaling network studied by (Goldbeter and Pourquie, 2008) to investigate
a remarkable example of biological rhythms, namely, the segmentation clock. These
two case studies validate our techniques and demonstrate good performance. The
1http://www.comp.nus.edu.sg/~rpsysbio/pada
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results reported show that the constructed DBN approximations have high quality and
the efficiency of performing parameter estimation and global sensitivity analysis has
been improved. It is worth noting that, in the first case study, we also compare the
performance (Section 6.1.4) of different sampling techniques presented in Chapter 4,
as well as the accuracies of approximations constructed using different discretization
schemes (Section 6.1.4). Furthermore, we also identified critical parameters in signal
transduction of the two pathways via rapid global sensitivity analysis.
The evaluations of our DBN approximation approach in the first and the second
case studies were done using synthetic (training) data. We further demonstrate the
capability and effectiveness of this approach by the third study (Section 6.3), which is
an integrated computational and experimental study of the regulatory mechanisms of
the human complement system. In this study, we built and analyzed a “live” pathway
model for the complement system in collaboration with Prof Ding Jeak Ling’s group
in Department of Biological Science, National University of Singapore and clinicians
from National University Hospital (Liu et al., 2011). To overcome the computational
challenges resulting from the large model size, we applied our techniques to train the
model on in vivo experimental data and explored the key network features of the model.
The results show the capability of our approach to deal with a large bio-pathway
especially in the context of performing tasks such as parameter estimation and global
sensitivity analysis. More importantly, this study has resulted in some crucial insights
into the complement regulatory mechanisms and has the potential to contribute to the
development of complement-based immunomodulation therapies.
6.1 The EGF-NGF Signaling Pathway
PC12 cells are a valuable model system in neuroscience. They proliferate in response
to EGF stimulation but differentiate into sympathetic neurons in response to NGF.
This interesting phenomenon has been intensively studied (Kholodenko, 2007). It has
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Figure 6.1: The reaction network diagram of the EGF-NGF pathway (Brown et al.,
2004)
been reported that the signal specificity is correlated with different Erk dynamics.
Specifically, a transient activation of Erk1/2 has been associated with cell proliferation,
while a sustained activity has been linked to differentiation. How EGF and NGF affect
the dynamics of active Erk through a network of intermediate signaling proteins is
shown schematically in Figure 6.1.
This model includes a common pathway to Erk through Ras shared by both the
EGFR and NGFR, and also two important side branches through PI3K and C3G.
This introduces multiple feedback loops leading to sophisticated dynamics. The ODE
model of this pathway is available in the BioModels database (Le Novere et al., 2006).
It consists of 32 differential equations and 48 associated rate parameters (estimated
from multiple sets of experimental data).
6.1.1 Construction of the DBN approximation
To construct the DBN approximation, we first derived its graph from its ODEs (see
Table 6.1). We then discretized the ranges of each variable and parameter into 5
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equal-size intervals and fixed the time step ∆t to be 1 minute. These choices were
made mainly in order to proceed with the DBN construction smoothly but without
trivializing the effort. Further, the experimental data (western blot) is such that 5
uniform intervals seemed a reasonable choice. However our construction can be easily
extended to non-uniform values intervals and time points. To fill up the conditional
probability tables associated with the nodes, 3× 106 trajectories were generated up to
100 mins by sampling initial states and parameters from the prior which are assumed
to be uniform distributions over certain intervals (Table 6.2 and Table 6.3). (Note that
our sampling scheme supports any assumed distributions of the prior, such as Gaussian
distributions.) Since we planned to study the effectiveness of our DBN based parameter
estimation method (Section 5.2), we singled out 20 of the 48 parameters to be unknown
(marked with * in Table 6.3) . When generating the 3× 106 initial states, the sampled
initial values of these parameters were chosen from their full range of possible values
and not biased towards any specific intervals.
These samples were generated using the direct sampling method. We recall that
in this method, the initial values of those trajectories are according to prior distri-
bution (except for the parameters designated to be “unknown” as described above).
Specifically, we randomly pick a value for each variable/parameter according to their
marginal prior and then form a vector of initial values. The computational workload
was distributed on 10 Opteron 2.2GHz processors in a cluster. It took around 4 hours
to construct the DBN approximation. All the subsequent experiments reported below
were done using an Intel Xeon 2.8GHz processor.
6.1.2 Probabilistic inference
To test the quality of our approximation, we implemented Monte Carlo integration
for the ODE model to get good estimates by sampling and averaging. Specifically,
we numerically generated a number of random trajectories -according to the prior-
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Name Variable Parents
EGF x1 k1, x1, x3, k2, x4
NGF x2 k3, x2, x5, k4, x6
free EGF Recepter x3 k1, x1, x3, k2, x4
bound EGF Recepter x4 k1, x1, x3, k2, x4
free NGF Recepter x5 k3, x2, x5, k4, x6
bound NGF Recepter x6 k3, x2, x5, k4, x6
inactive Sos x7 k9, x10, x8, x8, k10, k5, x4, x7, x7, k6, k7, x6, x7, x7, k8
active Sos x8 k9, x10, x8, x8, k10, k5, x4, x7, x7, k6, k7, x6, x7, x7, k8
inactive P90Rsk x9 k27, x21, x9, x9, k28
active P90Rsk x10 k27, x21, x9, x9, k28
inactive Ras x11 k11, x11, x11, k12, k13, x13, x12, x12, k14
active Ras x12 k11, x11, x11, k12, k13, x13, x12, x12, k14
active RasGap x13 x13
inactive Raf x14 k15, x12, x14, x14, k16, k45, x32, x15, x15, k46, k35, x25, x15, x15, k36
active Raf x15 k15, x12, x14, x14, k16, k45, x32, x15, x15, k46, k35, x25, x15, x15, k36
inactive B-Raf x16 k43, x29, x16, x16, k44, k47, x32, x17, x17, k20
active B-Raf x17 k43, x29, x16, x16, k44, k47, x32, x17, x17, k20
inactive Mek x18 k17, x15, x18, x18, k18, k19, x17, x18, x18, k48, k21, x31, x19, x19, k22
active Mek x19 k17, x15, x18, x18, k18, k19, x17, x18, x18, k48, k21, x31, x19, x19, k22
inactive Erk x20 k23, x19, x20, x20, k24, k25, x31, x21, x21, k26
active Erk x21 k23, x19, x20, x20, k24, k25, x31, x21, x21, k26
inactive PI3K x22 k29, x4, x22, x22, k30, k31, x12, x22, x22, k32
active PI3K x23 k29, x4, x22, x22, k30, k31, x12, x22, x22, k32
inactive Akt x24 k33, x23, x24, x24, k34
active Akt x25 k33, x23, x24, x24, k34
inactive C3G x26 k37, x6, x26, x26, k38
active C3G x27 k37, x6, x26, x26, k38
inactive Rap1 x28 k39, x27, x28, x28, k40, k41, x30, x29, x29, k42
active Rap1 x29 k39, x27, x28, x28, k40, k41, x30, x29, x29, k42
active RapGap x30 x30
active PP2A x31 x31
active RafPP x32 x32
Table 6.1: The DBN structure of the EGF-NGF signaling pathway model
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Probability distribution
x1 ∼ U(8801760.0, 1.10022× 107)
x2 ∼ U(401280.0, 501600.0)
x3 ∼ U(70400.0, 88000.0)
x4 ∼ U(0.0, 17600.0)
x5 ∼ U(8800.0, 11000.0)
x6 ∼ U(0.0, 2200.0)
x7 ∼ U(105600.0, 132000.0)
x8 ∼ U(0.0, 26400.0)
x9 ∼ U(105600.0, 132000.0)
x10 ∼ U(0.0, 26400.0)
x11 ∼ U(105600.0, 132000.0)
x12 ∼ U(0.0, 26400.0)
x13 ∼ U(105600.0, 132000.0)
x14 ∼ U(105600.0, 132000.0)
x15 ∼ U(0.0, 26400.0)
x16 ∼ U(105600.0, 132000.0)
x17 ∼ U(0.0, 26400.0)
x18 ∼ U(528000.0, 660000.0)
x19 ∼ U(0.0, 132000.0)
x20 ∼ U(528000.0, 660000.0)
x21 ∼ U(0.0, 132000.0)
x22 ∼ U(105600.0, 132000.0)
x23 ∼ U(0.0, 26400.0)
x24 ∼ U(105600.0, 132000.0)
x25 ∼ U(0.0, 26400.0)
x26 ∼ U(105600.0, 132000.0)
x27 ∼ U(0.0, 26400.0)
x28 ∼ U(105600.0, 132000.0)
x29 ∼ U(0.0, 26400.0)
x30 ∼ U(105600.0, 132000.0)
x31 ∼ U(105600.0, 132000.0)
x32 ∼ U(105600.0, 132000.0)
Table 6.2: Prior (initial) probability distribution of variables
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Parameter Range Nominal probability distribution
k1* [0, 4.37006× 10−5] k1 ∼ U(1.748024× 10−5, 2.622036× 10−5)
k2* [0, 0.0242016] k2 ∼ U(0.00968064, 0.01452096)
k3* [0, 2.76418× 10−7] k3 ∼ U(1.105672× 10−7, 1.658508× 10−7)
k4* [0, 0.01447622] k4 ∼ U(0.005790488, 0.008685732)
k5 [0, 1389.462] k5 ∼ U(555.7848, 833.6772)
k6 [0, 1.217214× 107] k6 ∼ U(4868856.0, 7303284.0)
k7 [0, 778.856] k7 ∼ U(311.5424, 467.3136)
k8 [0, 4225.32] k8 ∼ U(1690.128, 2535.192)
k9 [0, 3223.94] k9 ∼ U(1289.576, 1934.364)
k10 [0, 1793792.0] k10 ∼ U(717516.8, 1076275.2)
k11* [0, 64.688] k11 ∼ U(25.8752, 38.8128)
k12* [0, 71908.6] k12 ∼ U(28763.44, 43145.16)
k13 [0, 3018.72] k13 ∼ U(1207.488, 1811.232)
k14 [0, 2864820.0] k14 ∼ U(1145928.0, 1718892.0)
k15* [0, 1.768192] k15 ∼ U(0.7072768, 1.0609152)
k16 [0, 124929.2] k16 ∼ U(49971.68, 74957.52)
k17* [0, 371.518] k17 ∼ U(148.6072, 222.9108)
k18 [0, 9536700.0] k18 ∼ U(3814680.0, 5722020.0)
k19 [0, 250.178] k19 ∼ U(100.0712, 150.1068)
k20 [0, 315896.0] k20 ∼ U(126358.4, 189537.6)
k21 [0, 5.66486] k21 ∼ U(2.265944, 3.398916)
k22 [0, 1037506.0] k22 ∼ U(415002.4, 622503.6)
k23* [0, 19.70734] k23 ∼ U(7.882936, 11.824404)
k24 [0, 2014680.0] k24 ∼ U(805872.0, 1208808.0)
k25 [0, 17.7824] k25 ∼ U(7.11296, 10.66944)
k26 [0, 6992980.0] k26 ∼ U(2797192.0, 4195788.0)
k27* [0, 0.0427394] k27 ∼ U(0.01709576, 0.02564364)
k28* [0, 1527046.0] k28 ∼ U(610818.4, 916227.6)
k29* [0, 21.3474] k29 ∼ U(8.53896, 12.80844)
k30 [0, 369824.0] k30 ∼ U(147929.6, 221894.4)
k31 [0, 0.1542134] k31 ∼ U(0.06168536, 0.09252804)
k32 [0, 544112.0] k32 ∼ U(217644.8, 326467.2)
k33* [0, 0.1132558] k33 ∼ U(0.04530232, 0.06795348)
k34* [0, 1307902.0] k34 ∼ U(523160.8, 784741.2)
k35 [0, 30.2424] k35 ∼ U(12.09696, 18.14544)
k36 [0, 238710.0] k36 ∼ U(95484.0, 143226.0)
k37* [0, 293.824] k37 ∼ U(117.5296, 176.2944)
k38* [0, 25752.4] k38 ∼ U(10300.96, 15451.44)
k39* [0, 2.8029] k39 ∼ U(1.12116, 1.68174)
k40 [0, 21931.2] k40 ∼ U(8772.48, 13158.72)
k41* [0, 54.53] k41 ∼ U(21.812, 32.718)
k42 [0, 591980.0] k42 ∼ U(236792.0, 355188.0)
k43* [0, 4.4199] k43 ∼ U(1.76796, 2.65194)
k44* [0, 2050920.0] k44 ∼ U(820368.0, 1230552.0)
k45 [0, 0.252658] k45 ∼ U(0.1010632, 0.1515948)
k46 [0, 2123.42] k46 ∼ U(849.368, 1274.052)
k47 [0, 882.574] k47 ∼ U(353.0296, 529.5444)
k48 [0, 2.1759× 107] k48 ∼ U(8703600.0, 1.30554× 107)
Table 6.3: The range and nominal probability distributions of parameters. For un-
known parameters (marked with *), we assume the their prior are uniform distributions
over their ranges.
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Figure 6.2: Simulation results of the EGF-NGF signaling pathway. Solid lines represent
nominal profiles and dash lines represent DBN simulation profiles.
using ODEs and computed the average values of the variables at the chosen time
points. Our experiments show that the average values converge when the number
of random trajectories generated is roughly 104. The averaged trajectories projected
to individual protein concentration time series values are termed to be the nominal
simulation profiles.
Using the implemented FF algorithm the mean of each variable over time was
computed. In doing so, for the 20 parameters which were assumed to be unknown
during the DBN construction process, their values were presented as specific intervals
(derived from the original ODE model) in the form of evidence.
The time profiles resulting from the execution of the FF algorithm are termed to
be the DBN-simulation profiles. As summarized in Figure 6.2, our DBN-simulation
profiles fit the nominal simulation profiles quite well for most of the cases.
In terms of running time, a single execution of FF inference required 0.08 seconds
while generating a stable nominal profile requires 105.4 seconds. Thus, the total com-
putation time will be sharply reduced for our approach when many such “queries” need
to be answered.
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6.1.3 Parameter estimation
In order to test the performance of the DBN-based parameter estimation method, we
synthesized experimental time series data for 9 (out of 32) proteins {bounded EGFR,
bounded NGFR, active Sos, active C3G, active Akt, active p90RSK, active Erk, active
Mek, active PI3K}, measured at the time points {2, 5, 10, 20, 30, 40, 50, 60, 80, 100}
(min). This data was synthesized using prior knowledge about initial conditions and
parameters (see Table 6.2 and Table 6.3). To mimic western blot data which is cell
population based, we first averaged 104 random trajectories generated by sampling
initial states and rate constants, and then added observation noise with variance 5%
to the simulated values. With the assumed measurement precision, those values were
discretized into 5 intervals, which represent the concentration levels in western blot
data. We reserved the data of 7 proteins for training the parameters and reserved the
rest data for testing the quality of the estimated parameter values.
With 20 of the 48 parameters having been designated during the DBN construction
as being unknown, the Hooke & Jeeves algorithm was implemented to search in the
discretized parameter space. The estimated parameter values in terms of maximal
likelihoods of certain combination of interval values (of the 20 unknown parameters) can
be found in Table 6.4. As shown in Figure 6.3, the DBN-simulation profiles generated
using the estimated parameters matches the training data as shown and also has good
agreement with the test data.
We compared the efficiency and quality of our results with the following ODE-
based optimization algorithms: Levenberg-Marquardt (LM) (Levenberg, 2), Genetic
Algorithm (GA) (Back et al., 1997), Stochastic Ranking Evolutionary Strategy (SRES)
(Runarsson and Yao, 2000), and Particle Swarm Optimization (PSO) (Kennedy and
Eberhart, 1995). These optimization algorithms were executed using the COPASI
(Hoops et al., 2006) tool. We scored the resulting parameters obtained from all the
algorithms using the weighted sum-of-squares difference between the experimental data
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Parameter Range Posterior probability distribution
k1* [0, 4.37006× 10−5] k1 ∼ U(2.62204E × 10−5, 3.49605× 10−5)
k2* [0, 0.0242016] k2 ∼ U(0.01452096, 0.01936128)
k3* [0, 2.76418× 10−7] k3 ∼ U(1.65851× 10−7, 2.21134× 10−7)
k4* [0, 0.01447622] k4 ∼ U(0.011580976, 0.01447622)
k11* [0, 64.688] k11 ∼ U(38.8128, 51.7504)
k12* [0, 71908.6] k12 ∼ U(28763.44, 43145.16)
k15* [0, 1.768192] k15 ∼ U(1.4145536, 1.7681922)
k17* [0, 371.518] k17 ∼ U(74.3036, 148.6072)
k23* [0, 19.70734] k23 ∼ U(7.882936, 11.824404)
k27* [0, 0.0427394] k27 ∼ U(0, 0.00854788)
k28* [0, 1527046] k28 ∼ U(0, 305409.2)
k29* [0, 21.3474] k29 ∼ U(0, 4.26948)
k33* [0, 0.1132558] k33 ∼ U(0.06795348, 0.09060464)
k34* [0, 1307902] k34 ∼ U(784741.2, 1046321.6)
k37* [0, 293.824] k37 ∼ U(117.5296, 176.2944)
k38* [0, 25752.4] k38 ∼ U(20601.92, 25752.4)
k39* [0, 2.8029] k39 ∼ U(2.24232, 2.8029)
k41* [0, 54.53] k41 ∼ U(43.624, 54.53)
k43* [0, 4.4199] k43 ∼ U(3.53592, 4.4199)
k44* [0, 2050920] k44 ∼ U(1230552, 1640736)
Table 6.4: Parameter estimation results. The posterior distributions of unknown pa-
rameters inferred by our method.
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Figure 6.3: Parameter estimation results. (a) DBN-simulation profiles vs. training
data. (b) DBN-simulation profiles vs. test data.
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Figure 6.4: Performance comparison of our parameter estimation method (BDM) and
four other methods.
and the corresponding simulation profiles (i.e. low scores correspond to low errors).
The results are summarized in Figure 6.4, which suggests that our method achieves
a good balance between accuracy and performance. We also note that the cost of
constructing the DBN representation gets rapidly amortized.
6.1.4 Global sensitivity analysis
We modified and implemented the MPSA method for the DBN approximation setting.
Using the same experimental data set introduced in previous subsection, the global
sensitivities (K-S statistics) of the rate constants were computed. The results are
shown in Figure 6.5. The cumulative frequency distributions for the acceptable and
unacceptable cases can be found in Figure 6.6. Specifically, the reactions involved in
the phosphorylation of Erk (k23), Mek (k17), Akt (k34) and p90RSK (k28) have the
highest sensitivities, indicating that these reactions affect the system behavior most
directly. These results are consistent with previous findings (Kholodenko, 2007; Babu
et al., 2004).
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The MPSA method adopts Monte Carlo strategy for the ODE model. We recorded
the running time of the algorithm till the K-S values converged. The total running time
of the ODE-based MPSA method was about 22 hours, while the MPSA method based
on the DBN approximation required only 34 minutes. Thus the cost of constructing the
DBN approximation can be easily recovered when one performs parameter estimation
followed by sensitivity analysis.
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Figure 6.5: Parameter sensitivities
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Figure 6.6: Cumulative frequency distributions of the MPSA with respect to the un-
known parameters. Solid line denotes the acceptable samples and the dashed line
indicates the unacceptable samples. The sensitivity of a parameter is defined as the
maximum vertical difference between its two curves (K-S statistic) for the parameter.
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Different discretizations












































Figure 6.7: The effects of different discretizations. Solid black lines represent nominal
profiles, dash-dotted purple lines present BDM profiles with K = 8, dashed blue lines
present BDM profiles with K = 5, dotted cyan lines present BDM profiles with K = 3.
(b) Accuracy and efficiency comparison of different discretizations.
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Figure 6.8: Accuracy and efficiency comparison of different discretizations.
To evaluate the effects of different discretizations, we constructed DBN approxi-
mations for the EGF-NGF pathway by fixing K intervals for each variable, with K
ranging over {3, 4, 5, 6, 7, 8}. We then computed the mean of each variable over time
using FF algorithm for each DBN approximation. The resulting profiles were compared
with the nominal profiles. The comparison results are shown in Figure 6.7 . As might
be expected, as K increases, the quality of our approximations will improve. However,
since the time and space complexity of DBN based analysis depends on K, there is
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Figure 6.9: The comparison of two sampling methods. Solid lines represent direct
sampling with 3 millions samples and dash lines present J-coverage sampling with
J = 1000.
a tradeoff between efficiency and accuracy. To help decide on a good value of K, we
scored the discretizations with different Ks using the weight sum-of-square difference
between nominal profiles and DBN profiles, and measured the running time of a single
FF inference. The results are summarized in Figure 6.8 showing that discretizations
with 5 or 6 intervals might be good choices, at least in the present context.
Equation sampling
We also implemented the equation sampling method described in section 4 that pro-
vides a coverage of J samples for each possible combination of interval values of the
unknown parameters in each equation. Using this method, we generated 495, 000 tra-
jectories to get a coverage of 1000 per combination. Figure 6.9 shows the comparison
of time profiles generated the using two sampling methods. The two set of profiles are
nearly indistinguishable, suggesting that the equation sampling can efficiently reduce
the number of samples required. This also motivated us to conduct our next case study
using this method.
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Figure 6.10: Segmentation clock pathway (Goldbeter and Pourquie, 2008)
6.2 The Segmentation Clock Network
In the developing vertebrate embryos, the segmental pattern of the spine is established
when the somites are rhythmically produced. The periodic formation process of somites
is governed by an oscillator called the segmentation clock, which drives the oscillatory
expression of a large network of signaling genes (Dequeant et al., 2006). The underlying
signaling network proposed by Goldbeter and Pourquie (2008) is shown in Figure 6.10.
It couples three oscillating pathways consisting of the FGF, Wnt and Notch signaling
pathways, whose periodic behaviors are produced by negative feedback loops. The
corresponding ODE model can be accessed in the BioModels database (Le Novere et al.,
2006). It includes 21 differential equations and 75 associated rate parameters. Again,
anticipating our goal of evaluating the DBN based parameter estimation method, 39 of
the 75 parameter values were singled out to be unknown. The rest of the experiments
were conducted as described in our first case study.
6.2.1 Construction of the DBN approximation
We first constructed a DBN for the segmentation clock model. The graph of DBN is
shown in Table 6.5. Similar to the previous case study, we discretized the ranges of
each variable and parameter into 5 equal-size intervals and fixed the time step ∆t to
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be 5 minutes. To provide an equation of coverage of 1000 per combination, 2, 585, 000
trajectories were generated up to 500 mins by sampling the prior (Table 6.6 and Table
6.7). It is worth noting that even though equation sampling was used, a much larger
sample size (in relation to the first case study in the context of equation sampling) is
required due to the larger number of parameters and “fatness” (i.e. the number of pa-
rameters appearing on the right hand side) of the equations involved. The construction
process consumed around 3.1 hours on a cluster consisted of 10 processors.
Name Variable Parents
Notch protien x1 x1, x5, k1, k2, k3,
cytosolic NicD x2 x1, x2, x3, x5, k4, k5,
nuclear NicD x3 x2, x3, k4, k5, k6, k7,
Lunatic fringe mRNA x4 x3, x4, x21, k8, k11,
Lunatic Fringe protien x5 x4, x5, k12, k13, k14,
phosph. beta-catenin x6 x6, x10, x20, k15,
nuclear beta-catenin x7 x7, x10, k22, k23,
Axin2 protien x8 x8, x9, x11, x20, k19, k20,
Gsk3 x9 x8, x9, x20,
beta-catenin x10 x6, x7, x10, x20, k22, k23,
Axin2 mRNA x11 x7, x11, x14, k16, k17, k18,
active Ras x12 x12, x17, k28, k29, k35, k36,
active ERK x13 x12, x13, x16, x18, k27, k37,
active TF X x14 x13, x14, x19, k38, k39,
Dusp6 mRNA x15 x14, x15, k31, k32, k33, k34,
Dusp6 protien x16 x15, x16, k24, k25, k26,
inactive Ras x17 x12,
inactive ERK x18 x13,
inactive TF X x19 x14,
Axin2/Gsk3 destruction complex x20 x9,
vsFK x21 x9, k9, k10,
Table 6.5: The DBN structure of the segmentation clock pathway model. (Known
parameters are not shown in the parent sets)
6.2.2 Probabilistic inference
To generate stable nominal profiles, we averaged 104 trajectories according to the prior.
The nominal profiles were then compared with the DBN-simulation profiles computed
from the FF inference results. The comparison results are shown in Figure 6.11, which
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Probability distribution
x1 ∼ U(0.16, 0.2)
x2 ∼ U(0.0, 0.4)
x3 ∼ U(0.0, 0.02)
x4 ∼ U(0.0, 0.8)
x5 ∼ U(0.0, 0.8)
x6 ∼ U(0.08, 0.1)
x7 ∼ U(0.0, 0.2)
x8 ∼ U(0.0, 0.2)
x9 ∼ U(2.56, 3.2)
x10 ∼ U(0.0, 0.4)
x11 ∼ U(0.0, 3.2)
x12 ∼ U(0.44, 0.88)
x13 ∼ U(0.0, 0.44)
x14 ∼ U(0.0, 0.44)
x15 ∼ U(0.0, 1.4)
x16 ∼ U(0.0, 2.4)
x17 ∼ U(0.0, 0.4)
x18 ∼ U(0.0, 0.4)
x19 ∼ U(0.0, 0.4)
x20 ∼ U(0.0, 0.6)
x21 ∼ U(0.0, 0.6)
Table 6.6: Prior (initial) probability distribution of variables
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Parameter Range Nominal probability distribution
k1* [1.26, 1.54] k1 ∼ U(1.372, 1.428)
k2* [0.207, 0.253] k2 ∼ U(0.2254, 0.2346)
k3* [2.538, 3.102] k3 ∼ U(2.7636, 2.8764)
k4* [0.09, 0.11] k4 ∼ U(0.098, 0.102)
k5* [0.09, 0.11] k5 ∼ U(0.098, 0.102)
k6* [0.0009, 0.0011] k6 ∼ U(0.00098, 0.00102)
k7* [0.09, 0.11] k7 ∼ U(0.098, 0.102)
k8* [0.6912, 0.8448] k8 ∼ U(0.75264, 0.78336)
k9* [2.25, 2.75] k9 ∼ U(2.45, 2.55)
k10* [2.7, 3.3] k10 ∼ U(2.94, 3.06)
k11* [1.728, 2.112] k11 ∼ U(1.8816, 1.9584)
k12* [0.333, 0.407] k12 ∼ U(0.3626, 0.3774)
k13* [0.351, 0.429] k13 ∼ U(0.3822, 0.3978)
k14* [0.27, 0.33] k14 ∼ U(0.294, 0.306)
k15* [6.3558, 7.7682] k15 ∼ U(6.92076, 7.20324)
k16* [1.476, 1.804] k16 ∼ U(1.6072, 1.6728)
k17* [0.63, 0.77] k17 ∼ U(0.686, 0.714)
k18* [0.45, 0.55] k18 ∼ U(0.49, 0.51)
k19* [0.018, 0.022] k19 ∼ U(0.0196, 0.0204)
k20* [0.54, 0.66] k20 ∼ U(0.588, 0.612)
k21* [0.567, 0.693] k21 ∼ U(0.6174, 0.6426)
k22* [0.63, 0.77] k22 ∼ U(0.686, 0.714)
k23* [1.35, 1.65] k23 ∼ U(1.47, 1.53)
k24* [0.45, 0.55] k24 ∼ U(0.49, 0.51)
k25* [1.8, 2.2] k25 ∼ U(1.96, 2.04)
k26* [0.45, 0.55] k26 ∼ U(0.49, 0.51)
k27* [1.215, 1.485] k27 ∼ U(1.323, 1.377)
k28* [0.45, 0.55] k28 ∼ U(0.49, 0.51)
k29* [0.0927, 0.1133] k29 ∼ U(0.10094, 0.10506)
k30* [0.09, 0.11] k30 ∼ U(0.098, 0.102)
k31* [0.45, 0.55] k31 ∼ U(0.49, 0.51)
k32* [0.45, 0.55] k32 ∼ U(0.49, 0.51)
k33* [0.81, 0.99] k33 ∼ U(0.882, 0.918)
k34* [0.45, 0.55] k34 ∼ U(0.49, 0.51)
k35* [4.4712, 5.4648] k35 ∼ U(4.86864, 5.06736)
k36* [0.369, 0.451] k36 ∼ U(0.4018, 0.4182)
k37* [2.97, 3.63] k37 ∼ U(3.234, 3.366)
k38* [1.44, 1.76] k38 ∼ U(1.568, 1.632)
k39* [0.45, 0.55] k39 ∼ U(0.49, 0.51)
Table 6.7: The range and nominal probability distributions of unknown parameters.
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Figure 6.11: Simulation results of segmentation clock pathway. Solid lines represent
nominal profiles and dash lines represent DBN-simulation profiles.
shows a good fit between them. In terms of running time, a single execution of FF
inference required 0.01 seconds while generating a stable nominal profile took 407.3
seconds.
6.2.3 Parameter estimation
We next tested the performance of the DBN-based parameter estimation method. We
synthesized population based experimental time series data for 8 (out of 22) proteins
{Notch protein, nuclear NicD, Lunatic fringe mRNA, Axin2 mRNA, active ERK, Dusp6
mRNA, Dusp6 protein, cytosolic NicD}, measured at the time points {400, 410, 420,
430, 440, 450, 460, 470, 480, 490} (min) based on the prior knowledge about initial
conditions and parameters (see Tables 6.6 and Table 6.7). We averaged 104 random
trajectories generated by sampling initial states and rate constants, and then added
observation noise with variance 5% to the simulated values. The data of 6 proteins
were reserved for training the parameters and the rest data were used for testing the
quality of the estimated parameter values.
For the 40 parameters which had been designated to be unknown, the DBN based
implementation of Hooke & Jeeves algorithm was applied. The results can be found in
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Table 6.7. As shown in Figure 6.12 (a) and (b), the DBN-simulation profiles generated
using the estimated parameters obtained (with the match to training data as shown)
has good agreement with the test data.
We then compared the efficiency and quality of our results with the ODE-based opti-
mization algorithms: LM, GA, SRES, and PSO introduced in previous case study. The
results are summarized in Figure 6.12 (c) suggesting again that our method achieves a
good balance between accuracy and performance and the cost of constructing the DBN
representation gets rapidly amortized.







































































Figure 6.12: Parameter estimation results. (a) DBN-simulation profiles vs. training
data. (b) DBN-simulation profiles vs. test data. (c) Performance comparison of our
parameter estimation method (BDM) and 4 other methods.
6.2.4 Global sensitivity analysis
The global sensitivities of the parameters were computed using DBN based MPSA
method and are shown in Figure 6.13. Specifically, the reactions involved in the degra-
dation of Dusp6 mRNA (k34), the transcription of Dusp6 gene induced by TF X (k33)
and the transcription of the Axin2 gene induced by factor TF X (k18) have the highest
sensitivities, indicating that these reactions affect the system behavior most directly.
Since all these reactions are present in the FGF pathway, we hypothesize that FGF
pathway is the key regulatory mechanism that drives and synchronizes the oscillatory
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gene expression of segmentation clock.
The total running time of the ODE-based MPSA method was about 81.25 hours,
while the MPSA method based on the DBN required only 3.25 hours.

















Figure 6.13: Parameter sensitivities
6.3 The Complement System
The complement system is pivotal to defending against invading microorganisms. The
complement proteins recognize conserved pathogen-associated molecular patterns (PAMPs)
on the surface of the invading pathogens (Walport, 2001a) to initiate the innate im-
munity response. The complement proteins in the blood normally circulate as inactive
zymogens. Upon stimulation, proteases in the system cleave the zymogens to release
active fragments and initiate an amplifying cascade of further cleavages. The comple-
ment system constitutes over 30 proteins including serum proteins and cell membrane
receptors. There are three major complement activation routes: the classical, the lectin
and the alternative pathways (Walport, 2001b). Regardless of how these pathways are
initiated, the complement activity leads to proteolytic activation and deposition of the
major complement proteins C4 and C3, which induces phagocytosis, and the subsequent
assembly of the membrane attack complex which lyses the invading microbes. In the
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process, potent chemoattractant anaphylatoxins are released. However, complement is
a double-edged sword; adequate complement activation is necessary for killing the bac-
teria and removing the apoptotic cells, while excessive complement activation can harm
the host by generating inflammation and exacerbating tissue injury. Dysregulation of
the balance between complement activation and inhibition can lead to rheumatoid
arthritis (Okroj et al., 2007), systemic lupus erythematosus (Truedsson et al., 2007),
Alzheimer’s disease (Veerhuis et al., 2005) and age-related macular degeneration (An-
derson et al., 2010). Since the final outcome of complement related diseases may be
attributable to the imbalance between activation and inhibition, which is induced by in-
appropriate initiation of the cascade or deficiencies in specific regulators (Sjoberg et al.,
2009), manipulation of this balance using drugs represents an interesting therapeutic
opportunity awaiting further investigation. In light of this potential, complement in-
hibitors such as factor H and C4b-binding protein (C4BP) are critical since they play
important roles in tightly controlling the proteolytic cascade of complement and avoid-
ing excessive activation. Therefore, a systems-level understanding of the complement
activation and inhibition, as well as the roles of complement inhibitors, will contribute
towards the development of complement-based immunomodulation therapies.
As the frontline of host defense, complement is usually initiated by the interaction of
several pattern-recognition receptors with the surface of pathogens. C-reactive protein
(CRP), which is an acute phase reactant (Mold et al., 1981) and ficolins are two initia-
tors of the classical and lectin pathways, which boost immune responses by recognizing
phosphorylcholine (PC) or N-acetylglucosamine (GlcNAc), respectively, displayed on
the surface of invading bacteria (Marnell et al., 2005; Fujita et al., 2004; Ng et al.,
2007). Recently, it was discovered that under local infection-inflammation conditions
as reflected by pH and calcium levels, the conformations of CRP and L-ficolin change
which leads to a strong interaction between them (Zhang et al., 2009). This interaction
triggers crosstalk between classical and lectin pathways and induces new amplification
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mechanisms, which in turn reinforces the overall antibacterial activity and bacterial
clearance.
On the other hand, C4BP, a major complement inhibitor, is a large glycoprotein
synthesized and secreted by the liver. The estimated plasma concentration of C4BP
is 260 nM under normal physiological condition (Griffin et al., 1992). However, as
an acute phase reactant, its plasma level can be elevated up to four-fold during in-
flammation (Barnum and Dahlback, 1990; Boerger et al., 1987). Through its α-chain
(Blom et al., 2001, 1999), C4BP modulates complement pathways by controlling C4b-
mediated reactions in multiple ways: First, C4BP acts as a cofactor to factor I, in the
proteolytic inactivation of C4b, which prevents the formation and reconstitution of the
classical C3-convertase (C4bC2a) (Scharfstein et al., 1978). Second, C4BP prevents
the assembly of the classical C3 convertase by binding to nascent C4b, and accelerates
the natural decay of the C4bC2a complex (Gigli, 1979). Third, C4BP can compete
with C1q for the immobilized CRP (Sjoberg et al., 2006). Further, C4BP has been
proposed as a therapeutic agent for complement-related autoimmune diseases on the
premise that mice models supplemented with human C4BP showed attenuation in the
progression of arthritis (Blom et al., 2009). Therefore, it is important to understand
the systemic effect and the underlying inhibitory mechanism of C4BP.
With this background, we carried out a combined computational and experimental
study and obtained the following results.
6.3.1 Construction of the ODE model
A schematic representation of the complement system is shown in Figure 6.14. The re-
action network diagram of our model is shown in Figure 6.15. Processes such as protein
association, degradation and translocation are modeled with mass action kinetics and
processes such as cleavage, activation and inhibition with Michaelis-Menten kinetics.
The resulting ODE model was implemented using the open source software COPASI
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Figure 6.14: Simplified schematic representation of the complement system. The com-
plement cascade is triggered when CRP or L-ficolin is recruited to the bacterial surface
by binding to ligand PC (classical pathway) or GlcNAc (lectin pathway). Under inflam-
mation condition, CRP and ficolin interact with each other and induce amplification
pathways. The activated CRP and L-ficolin on the surface interacts with C1 and
MASP-2 respectively and leads to the formation of the C3 convertase (C4bC2a), which
cleaves C3 to C3b and C3a. Deposition of C3b initiates the opsonization, phagocytosis,
and lysis. C4BP regulates the activation of complement pathways by: (a) binding to
CRP, (b) accelerating the decay of the C4bC2a, (c) binding to C4b, and (d) preventing
the assembly of C4bC2a (red bars). Solid arrows and dotted arrows indicate protein
conversions and enzymatic reactions, respectively.
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(Hoops et al., 2006). It consists of 42 species, 45 reactions and 85 kinetic parameters
with 71 unknown. The details can be found in Liu et al. (2011).
6.3.2 Construction of the DBN approximation
We next constructed the DBN approximations of the ODE model to carry out param-
eter estimation and global sensitivity analysis.
In the ODE model the PC-initiated and GlcNAc-initiated complement cascades
were merged for convenience. By suppressing these two cascades one at a time (by
setting the corresponding expressions in the reaction equations to zero), we constructed
two DBNs; one for the PC-initiated complement cascade (Table 6.8) and the other for
GlcNAc-initiated complement cascade (Table 6.9). The range of each variable and
parameter was discretized into 6 non-equal size intervals and 5 equal size intervals,
respectively. The time points of interest were set to {0, 100, 200, . . . , 12600} (seconds).
Here 12600 seconds is equivalent to 3.5 hours, which is the largest time point of our
training experimental data. We then employed the equation sampling method (Section
4.3.2) with a coverage of 1000 to construct the two DBNs. Each of the resulting DBN
approximations encoded 1.2× 106 trajectories generated by sampling the initial values
of the variables and the parameters from the prior, which was assumed to be uniform
distributions over certain intervals (Liu et al., 2011). The computational workload was
distributed on 20 processors in a cluster and the running time was around 12 h.
6.3.3 Parameter estimation
The values of initial concentrations and 14 kinetic parameters were obtained from
literature data (Table 6.10 and Table 6.11). To estimate the remaining 71 kinetic
parameters, we generated training data by incubating human blood under normal and
infection-inflammation conditions with beads coated with PC or GlcNAc followed by
immunodetection of the deposited CRP, C4, C3 and C4BP in time series. For PC-
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Figure 6.15: The reaction network diagram of the mathematical model. Complexes
are denoted by the names of their components, separated by a “:”. Single-headed solid
arrows characterize irreversible reactions and double-headed arrows characterize re-
versible reactions. Dotted arrows represent enzymatic reactions. The kinetic equations
of individual reactions are presented in the supplementary material. The reactions with
high global sensitivities are labeled in red.
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Name Variable Parents
CRP px1 px1, px2, px3, k1, k2,
PC px2 px1, px2, px3, k1, k2,
PC/CRP px3 px3, pt9, pt10, pt11, pt12,
C4 px4 px4, pt1, pt2, pt3, pt4,
C4a px5 px4, px5,
C4b px6 px6, pt1, pt3, pt4, pt34, pa1,
C2 px7 px7, pt5, pt6, pt7, pt8,
C1 px8 px8, px19, pt15, pt16, k66,
PC/CRP/C1 px9 px3, px8, px9, k3, k4,
C2a px10 px10, pt5, pt13, pt14, pa2,
C2b px11 px7, px11,
C4b/C2a px12 px12, pt17, pt18, pt19, pt20,
C3 px13 px12, px13, k9,
C3a px14 px13, px14,
C3b px15 px12, px13, px15, k9, k89,
MASP px16 px16, px18, px24, pt30, k16, k64,
LF px17 px3, px17, px18, k28, k29,
PC/CRP/LF px18 px18, pt21, pt22, pt23, pt24,
PC/CRP/LF/MASP px19 px8, px19, pt31, k15, k66,
C4BP px20 px20, pt25, pt26, pt27, pt28, k88,
C4BP/PC/CRP px21 px3, px20, px21, k40, k41,
C4BP/C4b px22 px6, px20, px22, k45, k46,
C4b/C2a/C4BP px23 px12, px20, px23, k48, k49,
PC/CRP/LF/C1 px24 px16, px24, pt32, k53, k64,
C4BP/PC/CRP/LF px25 px18, px20, px25, k91, k92,
PC/CRP/LF/C1/MASP px26 px26, pt33, k65, k67,
TmpV art1 pt1 px4, px9, k5, k13,
TmpV art2 pt2 px4, px19, k17, k18,
TmpV art3 pt3 px4, px24, k54, k55,
TmpV art4 pt4 px4, px26, k68, k69,
TmpV art5 pt5 px7, px9, k6, k14,
TmpV art6 pt6 px7, px19, k30, k31,
TmpV art7 pt7 px7, px24, k56, k57,
TmpV art8 pt8 px7, px26, k70, k71,
TmpV art9 pt9 px1, px2, px9, k1, k4,
TmpV art10 pt10 px18, px21, k29, k41,
TmpV art11 pt11 px3, px8, k2, k3,
TmpV art12 pt12 px3, px17, px20, k28, k40,
TmpV art13 pt13 px12, px20, k8, k47,
TmpV art14 pt14 px6, px10, k7,
TmpV art15 pt15 px3, px8, px18, k3, k52,
TmpV art16 pt16 px9, px24, px26, k4, k53, k67,
TmpV art17 pt17 px2, px6, px10, k7, k49,
TmpV art18 pt18 px12, px20, k47,
TmpV art19 pt19 px12, px20, k8, k44,
TmpV art20 pt20 px12, px20, k48, k90,
TmpV art21 pt21 px16, px18, k16, k29,
TmpV art22 pt22 px3, px17, px19, k15, k28,
TmpV art23 pt23 px8, px18, px20, k52, k91,
TmpV art24 pt24 px24, px25, k53, k92,
TmpV art25 pt25 px3, px6, px20, k40, k46,
TmpV art26 pt26 px21, px22, k41, k45,
TmpV art27 pt27 px12, px18, px20, k48, k91,
TmpV art28 pt28 px23, px25, k49, k92,
TmpV art29 pt29 px12, px22, k8, k45,
TmpV art30 pt30 px19, px26, k15, k65,
TmpV art31 pt31 px16, px18, px26, k16, k67,
TmpV art32 pt32 px8, px18, px26, k52, k65,
TmpV art33 pt33 px8, px16, px19, px24, k64, k66,
TmpV art34 pt34 px6, px10, px20, k7, k46,
TmpV ara1 pa1 pt2, pt18, pt29,
TmpV ara2 pa2 pt6, pt7, pt8,
Table 6.8: The structure of DBN approximation of PC-initiated classical complement
pathway
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Name Variable Parents
CRP gx1 gx1, gx15, gx18, k32, k33,
C4 gx2 gx2, gt1, gt2, gt3, gt4,
C4a gx3 gx2, gx3,
C4b gx4 gx4, gt3, gt4, gt9, gt10, ga1,
C2 gx5 gx5, gt5, gt6, gt7, gt8,
C1 gx6 gx6, gt11, gt12,
C2a gx7 gx4, gx7, gt8, gt13, ga2, k7,
C2b gx8 gx8, gt5, gt6, gt7, gt8,
C4b/C2a gx9 gx9, gt14, gt15, gt16, k8,
C3 gx10 gx9, gx10, k9,
C3a gx11 gx9, gx10, gx11, k9,
C3b gx12 gx9, gx10, gx12, k9, k89,
MASP gx13 gx13, gx15, gt17, gt18, k21,
GlcNAc gx14 gx14, gx15, gx16, k19, k20,
GlcNAc/LF gx15 gx15, gt19, gt20, gt21, k20,
LF gx16 gx14, gx15, gx16, k19, k20,
GlcNAc/LF/MASP gx17 gx13, gx15, gx17, k21, k22,
GlcNAc/LF/CRP gx18 gx18, gt22, gt23, gt24, gt25,
GlcNAc/LF/CRP/C1 gx19 gx13, gx19, gt26, k1, k35,
C4BP gx20 gx9, gx20, gt27, gt28, k48, k88,
C4BP/GlcNAc/LF/CRP gx21 gx18, gx20, gx21, k42, k43,
C4BP/C4b gx22 gx4, gx20, gx22, k45, k46,
C4b/C2a/C4BP gx23 gx9, gx20, gx23, k48, k49,
GlcNAc/LF/CRP/MASP gx24 gx6, gx24, gt29, k59, k66,
GlcNAc/LF/CRP/C1/MASP gx25 gx25, gt30, k2, k67,
TmpV art1 gt1 gx2, gx17, k23, k24,
TmpV art2 gt2 gx2, gx19, k36, k37,
TmpV art3 gt3 gx2, gx24, k60, k61,
TmpV art4 gt4 gx2, gx25, k84, k85,
TmpV art5 gt5 gx5, gx17, k25, k26,
TmpV art6 gt6 gx5, gx19, k38, k39,
TmpV art7 gt7 gx5, gx24, k62, k63,
TmpV art8 gt8 gx5, gx25, k86, k87,
TmpV art9 gt9 gx9, gx22, k8, k45,
TmpV art10 gt10 gx4, gx7, gx20, k7, k46,
TmpV art11 gt11 gx19, gx25, k35, k67,
TmpV art12 gt12 gx6, gx18, gx24, k34, k66,
TmpV art13 gt13 gx9, gx20, k8, k47,
TmpV art14 gt14 gx4, gx7, gx23, k7, k49,
TmpV art15 gt15 gx9, gx20, k44, k47,
TmpV art16 gt16 gx9, gx20, k48, k90,
TmpV art17 gt17 gx17, gx24, gx25, k2, k22, k59,
TmpV art18 gt18 gx13, gx18, gx19, k1, k58,
TmpV art19 gt19 gx14, gx16, k19,
TmpV art20 gt20 gx17, gx18, k22, k33,
TmpV art21 gt21 gx1, gx13, gx15, k21, k32,
TmpV art22 gt22 gx1, gx15, gx19, k32, k35,
TmpV art23 gt23 gx21, gx24, k43, k59,
TmpV art24 gt24 gx13, gx18, gx20, k42, k58,
TmpV art25 gt25 gx6, gx18, k33, k34,
TmpV art26 gt26 gx6, gx18, gx25, k2, k34,
TmpV art27 gt27 gx21, gx22, gx23, k43, k45, k49,
TmpV art28 gt28 gx4, gx18, gx20, k42, k46,
TmpV art29 gt29 gx13, gx18, gx25, k58, k67,
TmpV art30 gt30 gx6, gx13, gx19, gx24, k1, k66,
TmpV ara1 ga1 gx9, gx20, gt1, gt2, k47,
TmpV ara2 ga2 gt5, gt6, gt7,
Table 6.9: The structure of DBN approximation of GlcNAc-initiated classical comple-
ment pathway
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beads, the concentration levels of deposited CRP, C4, C3 and C4BP were measured at
8 time points from 0 to 3.5 hours (Figure 6.16:A-B, red dots). For GlcNAc-beads, the
concentration levels of deposited MASP-2, C4, C3 and C4BP were also measured at 8
time points from 0 to 3.5 hours (Figure 6.16:C-D, red dots).
We then deployed the two-stage DBN based method to estimate unknown kinetic
parameters. As mentioned above, each unknown parameter’s value space was divided
into 5 equal intervals. In the first stage, we used stochastic ranking evolutionary strat-
egy (SRES) to search in the discretized parameter space consisting of 571 combinations
of interval values of the unknown parameters. The SRES search was done using a
modified version of the tool libSRES (Ji and Xu, 2006) (The modification enables one
to perform search in a discrete solution space). The result of this first stage was a
maximum likelihood estimate of a combination of intervals of parameter values.
In the first and the second case studies, we stopped with the first stage and worked
with this combination of intervals of parameter values. However, in this case study we
wanted to use the ODE model too for conducting in silico experiments such as varying
initial concentrations including the down and over expression of C4BP. This would have
been difficult to achieve by working solely with our current DBN approximation.
Thus, we then proceeded the second the stage and searched within this combination
of intervals having maximal likelihood. Consequently, the size of the search space for
the second stage was just 1/571 of the original search space. We performed the standard
SRES algorithm using libSRES tool to search for the vector of parameter values with
minimum objective value. The parameter values thus estimated are shown in Table
6.11.
Figure 6.16:A-D shows the comparison of the experimental time course training data
(red dots) with the model simulation profiles generated using the estimated parameters
(blue lines). The model predictions fit the training data well for most of the cases. In
some cases, the simulations were unable to reproduce the trends of the data well. This
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is likely due to the simplifications assumed by our model. For example, the species
that have not been included in the model may effect the fitting results.












































































































































































































































































































































































 experiments (killing rate)
BFigure 6.16: Experimental and simulated dynamics of the complement pathway. The
time profiles of deposited C3, C4, MASP-2, CRP and C4BP under the following four
conditions are simulated using estimated parameters and compared against the exper-
imental data: (A) PC-initiated complement activation under infla mation condition,
(B) PC-initiated complement activation under normal condition. (C) GlcNAc-initiated
complement activation under inflammation condition; (D) GlcNAc-initiated comple-
ment activation under normal condition. Blue solid lines depict the simulation results
and red dots indicate experimental data.
6.3.4 Model validation
We next validated the model using previously published experimental observations
(Zhang et al., 2009). In particular, normalized concentration level of deposited C3 was
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Table 6.10: The initial concentrations.




















kb011 1.45E − 4
kb012 0.07761722







kd011 7.07E − 5
kd012 7.23E − 5
kd041∗ 1.1
kd042∗ 2000.0
ke011 7.07E − 5
ke012 1.0E − 4




























































Table 6.11: Parameter values. Known parameters are marked with *.
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used to predict the antibacterial activity since C3 deposition initiated the opsonization
process and the lysis of bacteria. We first simulated the concentration level of deposited
C3 at 1 hour under different conditions. We next normalized the results so that the
maximum value among them equals to 95% which is the maximum bacterial killing rate
reported in the experimental observations (Zhang et al., 2009). The normalized values
were then treated as predicted bacterial killing rates. The simulation results are shown
in Figure 6.17:A and 6.17:B as black bars. Consistent with the experimental data
(Figure 6.17:A, grey bars), our simulation results showed that under the infection-
inflammation conditions, the P. aeruginosa can be efficiently killed (95% bacterial
killing rate) by complement whereas under the normal condition, only 28% of the
bacteria succumbed (Figure 6.17:A, black bars). In the patient serum, depletion of
CRP or ficolin induced a significant drop in the killing rate from 95% to 33% or 25%
respectively, indicating that the synergistic action of CRP and L-ficolin accounted for
around 40% of the enhanced killing effect. However, in the normal serum, depletion
of CRP or ficolin only resulted in a slight drop in the killing rate from 28% to 18%
or 10% respectively. Furthermore, simulating a high CRP level (such as in the case of
cardiovascular disease) under the normal healthy condition did not further increase the
bacterial killing rate. As shown in Figure 6.17:B, the simulation results matched the
experimental data. Thus, our model was able to reproduce the published experimental
observations shown in both Figure 6.17:A and 6.17:B with less than 10% error. This
not only validated our model thus promoting its use for generating predictions, but
also yielded positive evidence in support of the hypothesized amplification pathways
induced by infection-inflammation condition. It also suggested that the antibacterial
activity can be simulated efficiently by the level of deposited C3 and this was used to
generate model predictions described in later sections.
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Figure 6.17: Model predictions and experimental validation of effects of the crosstalk.
(A) Simulation results (black bar) of end-point bacterial killing rate in whole serum,
CRP depleted serum (CRP-), ficolin-depleted serum (ficolin-), both CRP- and ficolin-
depleted serum (CRP- & ficolin-) under normal and infection-inflammation conditions
agree with the previous experimental observations (gray bar). (B) The simulated bac-
terial killing effect of high CRP level agrees with the experimental data.
6.3.5 Sensitivity analysis
In order to identify critical reactions that control complement activation during infec-
tion, we performed global sensitivity analysis using the DBN approximations. Multi-
parametric sensitivity analysis (MPSA) (Zi et al., 2005) was performed on the DBN for
PC-initiated complement cascade (the details are presented in Section 5.3). The results
are shown in Figure 6.18. Strong controls over the whole system are distributed among
the parameters associated with the immobilisation of C3b with the surface, interaction
between CRP and L-ficolin, cleavage of C2 and C4, and the decay of C3 convertase
(see Figure 6.15, reactions labeled in red). The sensitivity of reactions associated with
C3, C2 and C4 highlight the significant role of major complement components. The
high sensitivity of interaction of CRP and L-ficolin confirms that the overall antibacte-
rial response depends on the strength of the crosstalk between the classical and lectin
pathways. In addition, since the decay of C3 convertase is one of the regulatory targets
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of C4BP, the sensitivity of the system to a change in the rate of decay of C3 convertase
suggested that the regulatory mechanism by C4BP plays an important role in comple-
ment. Since the critical reactions identified are common in PC- and GlcNAc-initiated
complement cascades, MPSA results using the other DBN will produce similar results
and hence this analysis was not performed. We next focused our investigation on the
enhancement mechanism by the crosstalk and the regulatory mechanism by C4BP.
Figure 6.18: Global sensitivity analysis. Global sensitivities were calculated according
to the MPSA method. The most sensitive parameters are colored in light blue. kc2
refers to the association rate of C3b with the surface. kd01 1 refers to the association
rate of CRP and ficolin. kd07 1 and kd 07 2 are the Michaelis-Menten constants gov-
erning the cleavage rate of C2. kd08 1 and kd 08 2 are the Michaelis-Menten constants
governing the cleavage rate of C4. kt03 1 refers to the decay rate of C4bC2a. Those
reactions are colored in red in Figure 6.15.
6.3.6 The enhancement mechanism of the antimicrobial response
Under infection-inflammation conditions where PC-CRP:L-ficolin or GlcNAc-L-ficolin:CRP
complex is formed, the amplification pathways are triggered. Model simulation showed
that if C1 and L-ficolin or CRP and MASP-2 competed against each other, the an-
tibacterial activity of the classical pathway or lectin pathway might be deprived of
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the amplification pathways. Therefore, in order to achieve a stable enhancement, C1
and L-ficolin (or CRP and MASP-2) must simultaneously bind to CRP (or L-ficolin).
Further, the abilities of CRP and L-ficolin to trigger subsequent complement cascade
were not affected by the formation of this complex. This is consistent with the previous
experimental observation that two amplification pathways co-exist with the classical
and lectin pathways (Zhang et al., 2009).
The pH value and calcium level influence the conformations of CRP and L-ficolin
which in turn govern their binding affinities. To investigate the effects of pH and
calcium on the antibacterial response, We simulated the C3 deposition dynamics using
the predicted binding affinities at pH ranging from 5.5 to 7.4 in the presence of 2 mM
and 2.5 mM calcium. The results are shown in Figure 6.19. Under both 2 mM and
2.5 mM calcium conditions, decreasing pH induces not only the increase of the peak
amplitude (maximum activation) but also hastens the peak time (time of maximum
activation).
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Figure 6.19: Simulation of antibacterial response with different pH and calcium level.
(A) The deposited C3 time profile at pH ranging from 5.5 to 7.4, in the presence of 2
mM calcium. (B) The deposited C3 time profile at pH ranging from 5.5 to 7.4, in the
presence of 2.5 mM calcium.
To further compare the effects of the two calcium levels, the dose-response curves
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were generated as shown in Figure 6.20. At 2 mM calcium (blue curve), the antibacterial
response was clearly greater than at 2.5 mM calcium (pink curve) indicating that slight
hypocalcaemia enhanced the antibacterial activity in a stable manner. In addition, the
pH-responses were reaching saturation levels when pH was near 5.5 (Figure 6.20),
implying that the undesirable complement-enhancement by extreme low pH condition
can be avoided. This also suggests that the saturation of the pH-response was influenced
by the calcium level in the milieu.
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Figure 6.20: The pH-antibacterial response curves of complement activation in the
presence of 2 mM calcium (pink) or 2.5 mM calcium (blue).
6.3.7 The regulatory mechanism of C4BP on the complement system
We next investigated the complement regulation by the major inhibitor, C4BP, under
infection-inflammation conditions.
We varied the initial concentration of C4BP and simulated the PC- and GlcNAc-
initiated complement under infection-inflammation conditions. The simulation time
was chosen to be 5 hours which is slightly beyond the largest time point of our train-
ing experimental data. The predicted effects of the initial concentration of C4BP on
the antibacterial response in terms of C3 deposition are shown in Figure 6.21:A-B.
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For PC-initiated complement activation, when the starting amount of C4BP was per-
turbed around the normal level of 260 nM (Griffin et al., 1992), increasing C4BP level
only delayed the peak time but did not decrease the peak amplitude significantly. In
contrast, reducing the initial C4BP level clearly hastened the complement activation
and maximized the activity. Interestingly, the GlcNAc-initiated complement activation
(Figure 6.21:B) behaved differently from the PC-mediated complement activation (Fig-
ure 6.21:A). Around the normal level of 260 nM, perturbing the initial C4BP changed
the maximum activity but did not affect the peak time, suggesting that C4BP plays






































































Figure 6.21: Model prediction of effects of C4BP under infection-inflammation condi-
tion. Predicted profiles of the deposited C3 after knocking down or over-expressing
C4BP in the presence of PC (A) or GlcNAc (B).
Our results imply that C4BP regulates the lectin pathway more stringently than
the classical pathway, which is consistent with previous experimental findings (Rawal
et al., 2009). Further, for PC-initiated complement cascade, the over-expression of
C4BP only delays but does not “turn off” the antibacterial response. In contrast,
increased C4BP can efficiently inhibit GlcNAc-initiated complement activation. This
may explain previous observations that bacteria such as Yersinia enterocolitica, Strep-
tococcus pyogenes, Neisseria gonorrhoeae, Escherichia coli K1, Moraxella catarrhalis,
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Candida albicans, Bordetella pertussis (Kirjavainen et al., 2008; Thern et al., 1995;
Ram et al., 2001; Prasadarao et al., 2002; Nordstrom et al., 2004; Meri et al., 2004;
Berggard et al., 1997) can exploit C4BP to evade complement.
We next investigated how C4BP mediates its inhibitory function. As shown in
Figure 6.14, the inhibitory effects of C4BP target different sites in complement: (a)
binding to CRP and blocking C1, (b) preventing the formation of C4bC2a by binding
to C4b, (c) acting as a cofactor for factor I in the proteolytic inactivation of C4b, and
(d) accelerating the natural decay of the C4bC2a complex, which prevents the for-
mation of C4bC2a and disrupts already formed convertase. To identify the dominant
mechanism, we employed in silico knockout of the reactions involved for each mecha-
nism and performed simulations. Figure 6.22 shows the model predictions. Among the
four inhibitory mechanisms, only the knockout of reaction (d) significantly enhanced
the complement activation suggesting that facilitating the natural decay of C4bC2a
(C3 convertase) is the most important inhibitory function of C4BP. This is consistent
with our previous observations derived from sensitivity analysis, which identified the
decay of C3 convertase as a critical reaction. In addition, as the inhibitory effect of
reaction (d) is stronger than others, knocking out reaction (a) and (b) can even reduce
the complement activity, which is counter-intuitive and emphasizes the significance
of the systems-level understanding. As the enhancement mechanism by the crosstalk
between CRP and L-ficolin occurs upstream of the cascade, we envisage C4BP acts
downstream to ’quality control’ and modulate C3 convertase activity. Thus our results
suggest that efficient regulation of complement can be achieved by targeting the C3
convertase, where the complement pathways merge.
Our model predictions on the effects of C4BP have been experimentally verified.
The experimental methods and data can be found in Liu et al. (2011).
CHAPTER 6. CASE STUDIES 115
0 1 2 3 4 5 
0 . 0 
0 . 2 
0 . 4 
0 . 6 
0 . 8 








 t i o
 n 
tim e [ h ] 
k no c k o u t a 
c on t r o l 
0 1 2 3 4 5 
0 . 0 
0 . 2 
0 . 4 
0 . 6 
0 . 8 








 t i o
 n 
tim e [ h ] 
k no c k o u t d 
c on t r o l 
0 1 2 3 4 5 
0 . 0 
0 . 2 
0 . 4 
0 . 6 
0 . 8 








 t i o
 n 
tim e [ h ] 
k no c k o u t b 
c on t r o l 
0 1 2 3 4 5 
0 . 0 
0 . 2 
0 . 4 
0 . 6 
0 . 8 








 t i o
 n 
tim e [ h ] 
k no c k o u t c 
c on t r o l 
D C 
B A 
E C4 cleavage (PC) 




0   10   20  30    1    1.5   2   2.5   3   3.5  
min h 
α chain (82 kDa) 
γ chain (35 kDa) 
Inactive fragment (18 kDa) 
α  chain (82 kDa) 
γ chain (35 kDa) 
Inactive fragment (18 kDa) 
α chain (82 kDa) 
γ chain (35 kDa) 
Inactive fragment (18 kDa) 
Figure 6.22: Knockout simulations reveal the major role of C4BP. (A) Simulation
profiles of C3 deposition with or without reaction a. (B) Simulation profiles of C3
deposition with or without reaction b. (C) Simulation profiles of C3 deposition with or
without reaction c. (D) Simulation profiles of C3 deposition with or without reaction d.
Reactions (a-d) are labeled red in Figure 6.14 and explained in the caption: (a) C4BP
binds to CRP, (b) C4BP binds to C4b, (c) C4BP prevents the assembly of C4bC2a,
and (d) C4BP accelerates the decay of the C4bC2a.
In summary, by integrating our computational model and experi ental observations
we have obtained novel insights into how the complement act vation is enhanced dur-
ing infection and how excessive complement activity may be avoided. This introduces
a new level of understanding of the host defense against bacterial infection. It also
provides a platform for the potential development of complement-based immunomod-




We have proposed a probabilistic approximation scheme for biological pathway dynam-
ics specified as a system of ODEs. Assuming a discretization and an initial distribution,
it consists of pre-computing and storing a representative sample of trajectories induced
by the system of ODEs. We use a dynamic Bayesian network representation to com-
pactly represent these trajectories by exploiting the pathway structure. Basically, the
underlying graph of the DBN approximation captures the dependencies of the variables
on other variables and rate constants as defined by the system of ODEs. Due to the
probabilistic graphical representation, a variety of analysis questions concerning the
pathway dynamics traditionally addressed using Monte Carlo simulations can be con-
verted to Bayesian inference and solved more efficiently. Using the FF algorithm for
doing basic Bayesian inference, we have adapted standard parameter estimation and
sensitivity analysis algorithms to the DBN setting.
We have demonstrated the applicability of our techniques with the help of the EGF-
NGF signaling pathway, the segmentation clock pathway and the complement system.
The DBN approximations we constructed successfully captured the dynamics of the
three pathways. We showed that with the DBN approximations the unknown rate
constants can be efficiently estimated from noisy experimental data.
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We also gained insights about the pathway dynamics by identifying critical param-
eters in signal transduction via global sensitivity analysis. At the end of performing
these analysis tasks we had easily regained the initial computational investment made
to construct the DBN approximation.
Apart from its computational efficiency, it is worth noting that the DBN approx-
imation is a more realistic model for recording the current state of knowledge about
a biological pathway. In particular, the probabilistic and intervals-based estimates it
returns will better match the noisy experimental data with limited precisions.
Turning next to the biological contributions of this thesis, in the third case study,
we developed an ODE-based model for the complement system accompanied by DBN
approximations. The motivation was to understand how the complement activity is
boosted under local inflammation conditions while a tight surveillance is established to
attain homeostasis.
Our study has involved a tight integration of computational and experimental as-
pects. The model analysis confirmed that the enhancement of complement activity
under infection-inflammation condition was attributable to the synergistic action of
CRP and L-ficolin and supported the existence of the amplification pathways. We also
showed that the antimicrobial response is sensitive to changes in pH and calcium levels,
which determines the strength of the crosstalk between CRP and L-ficolin.
Through model analysis we found that the inhibitor C4BP regulates the lectin
pathway more stringently than the classical pathway. The over-expression of C4BP
only delays but dose not reduce classical complement activation, whereas it attenuates
but does not delay the complement activation of lectin pathway. We also found that,
of the four documented inhibitory roles, C4BP acts mainly by facilitating the natural
decay of the C3 convertase. These predictions were validated empirically. As the
enhancement mechanism by the crosstalk between CRP and L-ficolin occurs upstream
of the cascade, we envisage C4BP acts downstream to ’quality control’ and modulate
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C3 convertase activity. Thus our results suggest that efficient regulation of complement
can be achieved by targeting the C3 convertase, where the complement pathways merge.
These insights concerning the regulatory mechanisms of the complement system can
potentially contribute to the development of complement-based immunomodulation
therapies.
7.1 Future Work
A crucial ingredient in the construction of the DBN is the family of sample trajectories
that are needed to get a good approximation. The DBN we construct approximates
idealized Markov chain induced by the ODEs dynamics. Given an error bound, a
confidence level and the transition probabilities of the idealized Markov chain, we can
estimate (upper bound) the sample size required to fall within the given error bound
with the required confidence level. However, the transition probabilities of the idealized
Markov chain will not computable. Hence we pragmatically determine the sample size
based on our sampling methods. How to determine the sample size with guaranteed
error bounds is an issue we are continuing to study.
Though it is only a one-time cost, generating a representative set of trajectories to
construct the DBN approximation for large pathway models will be computationally
intensive. In the studies presented in this thesis, we parallelized the DBN construction
code and executed it on a PC cluster. Clusters and supercomputers are expensive and
the resources are often shared by a crowd of researchers. To enhance the usability of our
approach, we are mapping our implementation onto graphics processing units (GPUs)
in a on-going work in collaboration with computer architecture experts. We have been
able to map the DBN construction process onto the GPU. A preliminary study of the
EGF-NGF signaling pathway show promising results by achieving 5 fold speedup when
compared to the cluster implementation present in this thesis (Chattopdhyay, 2010).
We are continuing to explore the applicability of GPUs in our setting.
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The long term aim of our approach is to aid biologists to understand the mechanisms
of biological pathways. On this light, we need to apply our method to a variety of
pathway models. We are currently doing so in collaboration with biologists in the
settings of Apoptosis/Autophage pathways and DNA damage/repair pathways.
Further, it will be useful to augment the ODE model with some discrete features
(e.g. HFPN models) but this should be easy to achieve.
The PRISM tool facilitates the rule-based stochastic formalisms to explore complex
properties of the pathway dynamics via probabilistic model checking. However, as the
state spaces of the underlying CTMCs of such models are exponential in the number
of species, analyzing large pathways will be computation prohibitive. Hence, it is also
important to develop formal verification techniques based on the DBN representation.
In this context, we note that the FF algorithm can compute -although approximately-
the marginal probabilities of the discretized values of variables at specific time points.
Hence it will be appropriate to develop probabilistic bounded model checking methods
for the DBN approximation and we are beginning to pursue this.
Related probabilistic formalisms such as Multi Terminal Binary Decision Diagrams
(MTBDDs) and Probabilistic Decision Graphs (PDGs) are available for model checking.
It is not clear at present how they can be derived directly from the ODE model. One
could however try to convert our DBNs to MTBDDs for purposes of model checking
(Langmead et al., 2006b) or develop statistical model checking methods (Jha et al.,
2009). As compact representations of the probability distributions, PDGs are, in spirit,
similar to Bayesian networks (Bozga and Maler, 1999) and can be computationally as
efficient as Bayesian networks (Jaeger, 2004). Further, probabilistic inference can be
carried out with a time complexity linear in the size of the PDGs (Jaeger, 2004). Thus,
it will be an interesting future direction for us to explore the performance of PDGs in
our setting.
Finally, our approximation technique might have wider applicability. A rich class
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of dynamical systems can be captured via ODEs and in a variety of situations it may
be appropriate and useful to abstract their behaviors as dynamic Bayesian networks as




This appendix contains the supplementary information for the third case study pre-
sented in Chapter 6. We first show the ODEs of the complement system model we
constructed. We then present the details of the materials and methods for generating
the experimental data we used in this case study. More information can be found in
Liu et al. (2011).
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A.1 The ODE Model
d ([CRP] )
dt
= − ((ka011 · [PC] · [CRP] − ka012 · [PC/CRP]))
− ((ke011 · [GlcNac/LF] · [CRP] − ke012 · [GlcNac/LF/CRP]))
d ([PC] )
dt
= − ((ka011 · [PC] · [CRP] − ka012 · [PC/CRP]))
d ([PC/CRP] )
dt
= + ((ka011 · [PC] · [CRP] − ka012 · [PC/CRP]))
− ((ka021 · [PC/CRP] · [C1] − ka022 · [PC/CRP/C1]))
− ((kf011 · [C4BP] · [PC/CRP] − kf012 · [C4BP/PC/CRP]))


















































































kg031 · [GlcNac/HF/MASP] · [C4]
kg032 + [C4]
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ka031 · [PC/CRP/C1] · [C4]
ka032 + [C4]
)
− ((kf041 · [C4BP] · [C4b] − kf042 · [C4BP/C4b]))
+ (kf05 · [C4b/C2a] · [C4BP])
+
(










kd101 · [PC/CRP/LF/C1/MASP] · [C4]
kd102 + [C4]
)
− ((kc011 · [C4b] · [C2a] − kc012 · [C4b/C2a]))
+
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= − ((ka021 · [PC/CRP] · [C1] − ka022 · [PC/CRP/C1]))
− ((ke021 · [GlcNac/LF/CRP] · [C1] − ke022 · [GlcNac/LF/CRP/C1]))
− ((kd051 · [PC/CRP/LF] · [C1] − kd052 · [PC/CRP/LF/C1]))
− ((kd091 · [PC/CRP/LF/MASP] · [C1] − kd092 · [PC/CRP/LF/C1/MASP]))
d ([PC/CRP/C1] )
dt
= + ((ka021 · [PC/CRP] · [C1] − ka022 · [PC/CRP/C1]))















ke041 · [GlcNac/LF/CRP/C1] · [C2]
ke042 + [C2]
)
+ (kf05 · [C4b/C2a] · [C4BP])
+
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ke071 · [GlcNac/LF/CRP/MASP] · [C2]
ke072 + [C2]
)
− ((kc011 · [C4b] · [C2a] − kc012 · [C4b/C2a]))
+
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= − (kf03 · [C4b/C2a] · [C4BP])
− (kf05 · [C4b/C2a] · [C4BP])
− ((kf061 · [C4b/C2a] · [C4BP] − kf062 · [C4b/C2a/C4BP]))
− (k1(tmp3) · [C4b/C2a])
+ ((kc011 · [C4b] · [C2a] − kc012 · [C4b/C2a]))
− ((kc041 · [C4b/C2a] − kc042 · [dC4b/C2a]))
d ([C3] )
dt
= − (kc02 · [C4b/C2a] · [C3])
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d ([C3a] )
dt
= + (kc02 · [C4b/C2a] · [C3])
d ([C3b] )
dt
= − (k1(tmp2) · [C3b])
+ (kc02 · [C4b/C2a] · [C3])
− ((kc031 · [C3b] − kc032 · [dC3b]))
d ([dC3b] )
dt
= + ((kc031 · [C3b] − kc032 · [dC3b]))
d ([MASP] )
dt
= − ((kb021 · [GlcNac/LF] · [MASP] − kb022 · [GlcNac/LF/MASP]))
− ((ke051 · [GlcNac/LF/CRP] · [MASP] − ke052 · [GlcNac/LF/CRP/MASP]))
− ((kd081 · [PC/CRP/LF/C1] · [MASP] − kd082 · [PC/CRP/LF/C1/MASP]))
− ((kg021 · [GlcNac/HF] · [MASP] − kg022 · [GlcNac/HF/MASP]))
− ((kd021 · [PC/CRP/LF] · [MASP] − kd022 · [PC/CRP/LF/MASP]))
d ([dC4b/C2a] )
dt
= − ((kf071 · [dC4b/C2a] · [C4BP] − kf072 · [dC4b/C2a/C4BP]))
+ ((kc041 · [C4b/C2a] − kc042 · [dC4b/C2a]))
d ([GlcNac] )
dt
= − ((kb011 · [GlcNac] · [LF] − kb012 · [GlcNac/LF]))
d ([GlcNac/LF] )
dt
= + ((kb011 · [GlcNac] · [LF] − kb012 · [GlcNac/LF]))
− ((kb021 · [GlcNac/LF] · [MASP] − kb022 · [GlcNac/LF/MASP]))
− ((ke011 · [GlcNac/LF] · [CRP] − ke012 · [GlcNac/LF/CRP]))
d ([LF] )
dt
= − ((kb011 · [GlcNac] · [LF] − kb012 · [GlcNac/LF]))
− ((kd011 · [PC/CRP] · [LF] − kd012 · [PC/CRP/LF]))
d ([GlcNac/LF/MASP] )
dt
= + ((kb021 · [GlcNac/LF] · [MASP] − kb022 · [GlcNac/LF/MASP]))
d ([PC/CRP/LF] )
dt
= − ((kd051 · [PC/CRP/LF] · [C1] − kd052 · [PC/CRP/LF/C1]))
− ((k1(tmpf1) · [C4BP] · [PC/CRP/LF] − k2(tmpf1) · [C4BP/PC/CRP/LF]))
+ ((kd011 · [PC/CRP] · [LF] − kd012 · [PC/CRP/LF]))
− ((kd021 · [PC/CRP/LF] · [MASP] − kd022 · [PC/CRP/LF/MASP]))
d ([PC/CRP/LF/MASP] )
dt
= − ((kd091 · [PC/CRP/LF/MASP] · [C1] − kd092 · [PC/CRP/LF/C1/MASP]))
+ ((kd021 · [PC/CRP/LF] · [MASP] − kd022 · [PC/CRP/LF/MASP]))
d ([GlcNac/LF/CRP] )
dt
= + ((ke011 · [GlcNac/LF] · [CRP] − ke012 · [GlcNac/LF/CRP]))
− ((ke021 · [GlcNac/LF/CRP] · [C1] − ke022 · [GlcNac/LF/CRP/C1]))
− ((kf021 · [C4BP] · [GlcNac/LF/CRP] − kf022 · [C4BP/GlcNac/LF/CRP]))
− ((ke051 · [GlcNac/LF/CRP] · [MASP] − ke052 · [GlcNac/LF/CRP/MASP]))
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d ([GlcNac/LF/CRP/C1] )
dt
= + ((ke021 · [GlcNac/LF/CRP] · [C1] − ke022 · [GlcNac/LF/CRP/C1]))
d ([C4BP] )
dt
= − ((kf011 · [C4BP] · [PC/CRP] − kf012 · [C4BP/PC/CRP]))
− ((kf021 · [C4BP] · [GlcNac/LF/CRP] − kf022 · [C4BP/GlcNac/LF/CRP]))
− ((kf041 · [C4BP] · [C4b] − kf042 · [C4BP/C4b]))
− ((kf061 · [C4b/C2a] · [C4BP] − kf062 · [C4b/C2a/C4BP]))
− ((kf071 · [dC4b/C2a] · [C4BP] − kf072 · [dC4b/C2a/C4BP]))
− (k1(tmp1) · [C4BP])
− ((k1(tmpf1) · [C4BP] · [PC/CRP/LF] − k2(tmpf1) · [C4BP/PC/CRP/LF]))
d ([C4BP/PC/CRP] )
dt
= + ((kf011 · [C4BP] · [PC/CRP] − kf012 · [C4BP/PC/CRP]))
d ([C4BP/GlcNac/LF/CRP] )
dt
= + ((kf021 · [C4BP] · [GlcNac/LF/CRP] − kf022 · [C4BP/GlcNac/LF/CRP]))
d ([iC4b/C2a] )
dt
= + (kf03 · [C4b/C2a] · [C4BP])
d ([C4BP/C4b] )
dt
= + ((kf041 · [C4BP] · [C4b] − kf042 · [C4BP/C4b]))
d ([C4b/C2a/C4BP] )
dt
= + ((kf061 · [C4b/C2a] · [C4BP] − kf062 · [C4b/C2a/C4BP]))
d ([dC4b/C2a/C4BP] )
dt
= + ((kf071 · [dC4b/C2a] · [C4BP] − kf072 · [dC4b/C2a/C4BP]))
d ([PC/CRP/LF/C1] )
dt
= + ((kd051 · [PC/CRP/LF] · [C1] − kd052 · [PC/CRP/LF/C1]))









= + ((ke051 · [GlcNac/LF/CRP] · [MASP] − ke052 · [GlcNac/LF/CRP/MASP]))
d ([PC/CRP/LF/C1/MASP] )
dt
= + ((kd081 · [PC/CRP/LF/C1] · [MASP] − kd082 · [PC/CRP/LF/C1/MASP]))
+ ((kd091 · [PC/CRP/LF/MASP] · [C1] − kd092 · [PC/CRP/LF/C1/MASP]))
d ([GlcNac/HF] )
dt
= + ((kg011 · [X] · [HF] − kg012 · [GlcNac/HF]))
− ((kg021 · [GlcNac/HF] · [MASP] − kg022 · [GlcNac/HF/MASP]))
d ([HF] )
dt
= − ((kg011 · [X] · [HF] − kg012 · [GlcNac/HF]))
d ([GlcNac/HF/MASP] )
dt
= + ((kg021 · [GlcNac/HF] · [MASP] − kg022 · [GlcNac/HF/MASP]))
d ([X] )
dt
= − ((kg011 · [X] · [HF] − kg012 · [GlcNac/HF]))
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A.2 Experimental Materials and Methods
Antibodies, proteins & sera
Human C1 complex protein was purchased from Sigma-Aldrich (St. Louis, MO). Hu-
man C4b-binding protein was from Complement Technology (Tyler, Texas). Goat
anti-rabbit secondary antibody with HRP conjugation, polyclonal rabbit anti-C3d and
anti-C4c antibodies were purchased from Dako A/S (Glostrup, Denmark). Secondary
anti-sheep antibody was from Upstate (Lake Placid, NY). Rabbit anti-human C4BP
antibody and mouse anti-human C4BP antibody targeting N-terminal part of C4BP
were raised according to standard protocols. C4BP used as standard for ELISA was
purified from human plasma (Zadura et al., 2009; Dahlback, 1983). Serum samples were
obtained from healthy adults and infected patient volunteers with informed consent.
As an infecion marker, the CRP levels in the serum samples were determined using
the CRP Bioassay ELISA kit (BD Biosciences, San Jose, CA) to confirm the healthy
and infectious status of the samples. All experiments were performed according to na-
tional and institutional guidelines on ethics and biosafety (Institutional Review Board,
Reference Code: NUS-IRB 08-296).
Manipulation of C4BP level in the serum
The level of C4BP in the serum was increased by exogenously adding 100 µg purified
C4BP protein per ml serum. The C4BP level in the serum was reduced by immuno-
precipitation. One ml of serum was pre-cleared using 20 µl Protein G Sepharose (GE
healthcare, Uppsala, Sweden) at 4◦C for 1 hour with gentle shaking. Sheep polyclonal
anti-C4BP antibody (GeneTex Inc, Irvine, CA) was incubated with the pre-cleared
serum with gentle shaking at 4◦C for 1 hour. Protein G Sepharose (20 mul) was then
added to the serum containing the antibody-C4BP complex with gentle shaking at 4◦
C for 1 hour. The supernatant with reduced C4BP level was stored. For both treated
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and untreated serum samples, C4BP level was measured by C4BP sandwich ELISA
to ensure the successfully addition and depletion of C4BP (Figure A.3). 10% (v/v)
healthy serum, which was used in the subsequent experiments, was prepared by dilut-
ing the serum from healthy adult, in TBS buffer (25 mM Tris, 145 mM NaCl, pH 7.4,
2.5 mM CaCl2) and 10% (v/v) patient serum was prepared by diluting in MBS buffer
(25 mM MES, 145 mM NaCl, pH 6.5, 2.0 mM CaCl2).
C4BP quantification by sandwich ELISA
To compare the C4BP levels between treated and untreated sera, sandwich ELISA
was performed. 10 µl/ml of rabbit anti-human C4BP antibody in 50 µl coating buffer
(75 mM sodium carbonate, pH 9.6) was immobilized on 96-well Maxisorp plates (Nunc,
Roskilde, Denmark) by incubating overnight at 4◦C. After four washes with wash buffer
(50 mM Tris-HCL, pH 8.0 supplemented with 2 mM CaCl2, 0.15 M NaCl, 0.1% (v/v)
Tween-20), the wells were blocked with blocking buffer (1% BSA (w/v) in TBS) at
37◦C for 1 hour. Following four washes, treated and untreated sera were diluted 2000
times in blocking buffer and 50 µl was added to the wells and incubated at 37circC
for 1 hour. After four washes, C4BP protein amount was detected with mouse anti-
C4BP antibody (1 : 15000) followed by rabbit anti-mouse HRP-conjugated secondary
antibody (1 : 2000). ABTS substrate (Roche Diagnostics, Mannheim, Germany) was
added and the OD405nm was read. Wells incubated with blocking buffer instead of
serum served as a negative control.
Complement measurement by pull-down with GlcNAc- and PC- beads
Untreated serum or sera with increased or decreased C4BP from both healthy adults
and patients were challenged with GlcNAc-Sepharose (Sigma-Aldrich) to initiate L-
ficolin-mediated complement activation. 20 µl of GlcNAc beads was added to 500
µl of 10% serum. The beads were collected between 0.5 to 4.0 hours at intervals of
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0.5 hour. For patient’s serum, the beads also underwent incubation at shorter time
intervals of 0, 10 and 20 minutes. For CRP-mediated pathway, PC-Sepharose (Pierce,
Rockford, IL) was used in place of GlcNAc-Sepharose. Beads were washed thrice with
their corresponding incubation buffer and boiled in SDS-PAGE sample buffer.
Western blot
Protein samples of the different time points obtained from the previous step was elec-
trophoresed on 12% SDS-PAGE. The primary antibodies used were polyclonal sheep
anti-C4BP, polyclonal rabbit anti-C4c and polyclonal rabbit anti-C3d at dilutions of
1 : 1000. Secondary antibodies used were rabbit anti-sheep and goat anti-rabbit at dilu-
tions of 1 : 15000 and 1 : 2000 respectively. The fractionated proteins were transferred
to PVDF membranes (Bio-Rad). Membrane blots were incubated in blocking buffer
(3% skimmed milk (w/v) in TBS) overnight at 4circC. Primary antibodies were diluted
in TBS supplemented with 3% (w/v) BSA, 0.5% (v/v) Tween-20 and reacted with the
blots with gentle shaking for 2 hours at room temperature. After washing 4× for 15
minutes each with wash buffer (TBS supplemented with 0.5% (v/v) Tween-20), the
blots were incubated with HRP conjugated secondary antibodies with gentle shaking
for 2 hour at room temperature. Visualization was performed with the use of Super-
Signal West Pico Chemiluminescent Substrate from Thermo Scientific (Rockford, IL)
and exposed through X-ray. Densitometric analysis of the blots was performed using
GS-800 Calibrated Densitometer (Bio-Rad). Fixed amount of pure proteins were used
as positive controls and the amounts of protein on different gels were normalized to
the positive control and compared with each other. Data are representative of three
independent experiments.
























Figure A.1: Time serials experimental data under inflammation and normal conditions.
(A) PC-initiated complement activation, (B) GlcNAc-initiated complement activation.
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Figure A.2: Experimental verification of effects of C4BP under infection-inflammation
condition. Profiles of deposited C4BP or C3 across time points of 0 − 4 hours under
infection-inflammation condition via classical pathway (triggered by PC beads) or lectin
pathway (triggered by GlcNAc beads) in untreated or treated sera with increased C4BP
or decreased C4BP, were studied. The deposited protein was resolved in 12% reducing
SDS PAGE and detected using polyclonal sheep anti-C4BP. Same amount of pure
protein was loaded to each of the gels as the positive control (labeled as “C” in the
image). The black triangles point to the peaks of the time serials data.
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Figure A.3: C4BP levels measured by C4BP sandwich ELISA for both treated and
untreated serum samples.
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Figure A.4: (Experimental verification of the role of C4BP. Profiles of deposited
cleaved/uncleaved C4 fragments across time points of 0 − 3.5 hours under infection-
inflammation condition occurring via classical pathway (triggered by PC beads) in
untreated or treated sera with increased C4BP or decreased C4BP were studied. The
black triangles point to the first appearance of inactive fragments.
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